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Zusammenfassung
Mikroorganismen verwenden meist “Zweikomponentensysteme” zur Wahrnehmung ihrer
Umweltbedingungen und man findet sie in unterschiedlicher Zahl in den Genomen fast aller
Bakterien und Archaeen. Ein typisches Zweikomponentensystem besteht aus einer His-
tidinkinase als Sensor und einem Antwortregulator, welcher von der Kinase phosphoryliert
wird. Der Antwortregulator fungiert meist als Transkriptionsfaktor und reguliert die Gen-
expression. Aufgrund ihrer Verbreitung in Mikroorganismen ermöglicht ein grundlegendes
Verständnis der Funktionsweise von Zweikomponentensystemen Einblicke in die Mecha-
nismen prokaryotischer Signalverarbeitung. Trotz einiger in vitro Studien fehlt bisher
die Beschreibung eines vollständigen Netzwerkes von Zweikomponentensystemen in vivo.
In einer systemweiten Studie im Bakterium Escherichia coli haben wir die Lokalisierung
von Signaltransduktionsproteinen und die Wechselwirkungen zwischen Systemen auf ver-
schiedenen Ebenen untersucht. Dafür konstruierten wir eine umfassende Bibliothek von
fluoreszenten Kinase- und Regulatorfusionen und analysierten ihre Lokalisierung inner-
halb der Zelle mittels Fluorezenzmikroskopie. Wir sahen für die meisten Sensoren eine
intrinsische Tendenz zur Komplexbildung, welche wahrscheinlich ein Gerüst zur Informa-
tionsverarbeitung bietet und Systeme gegen störende Einflüsse von außen schützt. Mittels
systematischer in vivo FRET-Mikroskopie untersuchten wir systematisch die Interaktio-
nen zwischen den einzelnen Proteinen. Für die meisten Sensoren konnten wir die Bildung
von Dimeren oder Oligomeren in vivo bestätigen. Den Sensor BaeS charakterisierten wir
durch die induzierte Konformationsänderung auf Grund von Stimulationen. Zusätzlich
fanden wir einige Signaltransduktionswege, welche auf Sensorebene oder zwischen Kinasen
und nicht zugehörigen Regulatoren interagieren. Diese bilden eine weitere Ebene der Sig-
nalverarbeitung. Mittels Durchflusszytometrie und einer fluoreszenten Promotorkollektion
konnten wir für einige dieser Interaktionen die physiologische Relevanz auf Genexpression-
sebene bestätigen. Jedoch fanden wir keinen Effekt der meisten beschriebenen Stimuli auf
die Genexpression von Zweikomponentensystemen. Abschließend liefern unsere Ergebnisse
ein detailierteres Verständnis der räumlichen Organisation von E. coli Zweikomponenten-
systemen und deren Wechselwirkungen untereinander. Diese erweitern das Verständnis
bakterieller Signaltransduktion.
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Summary
Microorganisms commonly use ‘two-component’ signaling systems for sensing environmen-
tal conditions, with members being present in nearly all bacterial and archaeal genomes
in different numbers. Prototypical two-component systems are comprised of a sensory his-
tidine kinase and a response regulator protein that is phosphorylated by the kinase. The
regulator typically acts as a transcription factor regulating gene expression. Due to their
prevalence in microorganisms, a basic understanding of the principles of two-component
systems provides insights into mechanisms of prokaryotic signaling circuits. Apart from a
few studies performed in vitro, the signaling properties of a whole bacterial two-component
network in vivo remains largely unclear. Using a system level approach, we characterized
the localization of signaling proteins and the interactions between pathways on different
levels in the model bacterium Escherichia coli. We constructed a comprehensive library
of fluorescent protein fusions to kinases and regulators from two-component systems, and
applied fluorescence microscopy to analyze their spatial organization within the cell. We
found that most of the sensors exhibit a intrinsic tendency for cluster formation, which
might provide a scaffold for information processing and insulation against detrimental noise
from other sources. We used in vivo FRET microscopy tools to study protein interactions
in a systematic way. For kinases, we could confirm the formation of sensor dimers or higher
order oligomers in vivo in most of the cases. For the sensor BaeS, we characterized the
change of sensor confirmation upon stimulation. Additionally, we identified a few path-
ways exhibiting interconnections on the sensor level and between sensors and non-cognate
regulators, providing an additional layer of information processing. We could confirm the
physiological relevance of some of these pathway interconnections on the gene expression
level, using flow cytometry measurements of a fluorescent promotor library. Moreover,
using this library we found most of the reported stimuli not affecting two-component gene
expression. Taken together, our data provide a deeper understanding of cellular organiza-
tion within and interconnections between different two-component systems in E. coli. The
results of this study can broaden the understanding of cell signaling principles in bacteria.
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1 Introduction
1.1 Bacterial signaling
Microorganisms are the oldest and most successful form of life and ubiquitous in the earth´s
biosphere. Notwithstanding the majority of prokaryotes remains to be characterized [1],
they outnumber all other species and despite their small size, they account for a biomass
exceeding those formed by all other higher organisms [2, 3]. Prokaryotes occupy all possible
habitats either as free living single cells, in cell communities or as symbionts or parasites in
close association with other organisms. Because of differences in lifestyles, they must sense
and respond to a large variety of external and internal signals. These include for example
changes in metabolism, nutrient availability, stress-responses, signals for biofilm formation
or virulence factors. To perform this tasks prokaryotes developed several different ways of
receiving signals and transmitting the input to an appropriate response inside the cell [4].
The successful processing of information and responding appropriately allows adaptation,
maintainance of viability, and the movement towards more favourable conditions. In most
cases, cellular responses operate on a genetic level, converting a received signal into a
changed gene expression pattern.
The signal transduction systems developed by prokaryotes can be classified in three
major classes, depending on the location of the stimulus source:
• transmembrane signaling
• cell-cell communication and
• intracellular signal transduction.
These classes contain different architectures of sensory transduction networks, which are
encoded into the bacterial genomes. The most prevalent and evolutionarily oldest pathways
are so-called one-component systems [5], which are ubiquitous among bacteria and archaea.
The second most frequent bacterial signaling pathways are two-component systems (TCS)
which are the subject of this study. Additionally, there is a range of different signal
transduction systems such as phosphotransferase systems (PTS) [6] and signaling systems
17
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mediated by small molecules like cyclic-di-GMP, cAMP or ppGpp [7, 8] or small regulatory
RNAs [9]. This work focuses on the signaling network of two-component systems in the
gram-negative enterobacterium Escherichia coli K-12 [10, 11], a commonly used model
organism in (molecular) microbiology.
1.2 Two-component systems
Two-component systems (TCS) are one of the most widespread signaling systems in prokary-
otes and lower eukaryotes, with pathways being present in nearly all bacteria and many
archaea in different numbers (Bacillus subtilis : 32, Helicobacter pylori : 3, Methanobac-
terium thermoautotrophicum: 29, Ktedonobacter racemifer DSM 44963 : 366) [12]. They
also occur in eukaryotes like the budding yeast Saccharomyces cerevisiae, the slime mold
Dictyostelium discoideum or the plant Arabidopsis thaliana with 1, 11 and 4 systems, re-
spectively [13, 14]. The number of systems seems thereby to depend on the organism´s
environment and the number of signals it is exposed to, with free living bacteria harbouring
more systems than parasites [15, 16]. Additionally, TCS numbers exhibit a positive corre-
lation with the genome size [5]. Interestingly, TCS seem to be completely absent from the
animal kingdom [17], as so far no genes coding for sensors or regulators have been found in
the genomes of Caenorhabditis elegans [18], Drosophila melanogaster [19] or Homo sapiens
[20]. This fact makes them an attractive target for new kinds of specific antimicrobial
agents [21, 22]. What makes them suitable to study basic principles of signal transduction
is the relatively simple layout and the modularity in their design (Figure 1.1).
They are comprised out of only two proteins, a sensor histidine kinase (HK) and a cy-
toplasmic response regulator (RR) [13]. Upon activation through a certain stimulus, the
sensor kinase gets autophoshorylated at a histidine residue. The phosphoryl group is sub-
sequently transferred to a specific aspartate residue on the response regulator that acts in
most of the cases as a transcription factor regulating downstream gene expression. There
are kinases, referred to as orthodox kinases, that perform a direct phosphotransfer from
the sensor to the response regulator. Additionally, there are more elaborate ways of phos-
photransfer such as hybrid kinases or phosphorelays [13, 23] (Figure 1.2). Those sensors
include additional intramolecular domains harbouring Asp and His residues, allowing a
multistep phosphotransfer within the kinase before phosphorylation of the response reg-
ulator. Those systems account for about 25 % of all known two-component sensors [24].
It is not clear why some pathways are designed as phosphorelays instead of a orthodox
two-component system. It is believed that those multistep relays allow further control of
18
1.2 Two-component systems
the signal transduction cascade as for example exhibited by the regulation of B. subtilis
sporulation [25]. Another hypothesis is that multiple steps could provide a filter against
noise in the input signals [26], but this has yet to be confirmed experimentally. In E. coli,
5 out of 30 sensors (ArcB, BarA, EvgS, RcsC, TorS) are hybrid kinases [15]. An overview
▼
▼
RR P
▼
RR
HK
Figure 1.1: Schematic representation of two-component systems architecture. A prototypical
two-component system contains a histidine kinase dimer (HK) located in the cytoplasmic
membrane, acting as a sensor. RR represents the cytoplasmic dimeric response regulator,
which is phosphorylated (P) through the kinase resulting in binding to a promotor region on
the genome. The polycyclic hydrocarbon structure symbolizes the (periplasmic) stimulus
of the system.
of all TCS from E. coli is depicted in Table 1.1. TCS show a high degree of homology
between different systems and even organisms [27]. Given that, a basic understanding of
the principles of two-component system would provide the insight into the mechanisms of
virulence or pathogenicity [28] or allow construction of novel signaling circuits and genetic
networks using synthetic biology or metabolic engineering [29, 30].
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Table 1.1: Overview of two-component systems in Escherichia coli . A list of all identified two-
component systems in E. coli with their corresponding downstream target promotor and
stimuli. Modified after [4].
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1.2 Two-component systems
1.2.1 Histidine kinases
Stimulus perception in two-component systems is performed by sensor or histidine kinases
[13, 23]. The basic principle of kinase domain organization is shown in Figure 1.2, the
structural details are depicted in Figure 1.3.
N C
TM     TM           H      X         N     D     F     G               D               H
  DHp domain      CA domain                   only in hybrid kinases
 Transmitter                       Receiver       HPt
Sensor
domain
(periplasmic)
Linker
region
(cytoplasmic)
Figure 1.2: Domain organization of histidine kinases. Majority of sensors contain a N-terminal
(periplasmic) sensing domain for stimulus perception, which is surrounded by two trans-
membrane (TM) domains. The following linker region connects the TM with the cyto-
plasmic transmitter module, containing the DHp and CA domains. DHp harbours the
conserved histidine residue (H). Single letters describe homology motifs inside the mod-
ule (details: see text). Hybrid kinases additionally contain C-terminal Receiver and HPt
domains with additional histidine and aspartate (D) residues building a phosphorelay.
(modified after [23])
It contains two N-terminal transmembrane domains (TM), which surround a sensor do-
main for periplasmic sensing kinases (details, see below). On the cytoplasmic side the TM
region is followed by a HAMP domain (named after their conservation among histidine
kinases, adenylyl cyclases, methyl-accepting proteins, phosphatases), transmitting infor-
mation via a piston-like movement from the outside to the cytoplasmic parts of the sensor.
The following transmitter part is composed of two domains, the DHp (dimerization and
histidine phosphotransfer) and the CA (catalytic activity and ATPase) domain. The DHp
domain contains a conserved histidine residue that is involved in the signal transmission
through phosphorylation. The CA domain is responsible for catalyzing autophosphoryla-
tion of the sensor using ATP, which binds to the ATP-lid between the G1 and G2 boxes
of the CA domain.
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a         b
Figure 1.3: 3D structures of common histidine kinase domains. (a) Alternative designs for
periplasmic sensing domains showing structures from E. coli DcuS and NarX sensors.
Individual monomers are depicted in green and blue, respectively, modeled TM domains
are shown in grey. The corresponding signal molecules malate and nitrate bound to DcuS
and NarX, respectively, are depicted in yellow. (b) Structural representation of cytoplasmic
HK domains with the HAMP domain from Archaeoglobus fulgidus Af1503 (HAMP) and
the transmitter domain from Thermotoga maritima HK853 (Kinase core). All domains
exhibit a dimeric structure and are shown in different colours. Red arrow in TM2 repre-
sents proposed piston-like movement upon stimulation for signal transmission. Conserved
His-residue in the kinase core is shown as green pentagon. Violet 3D structure represents
a RR which accesses the kinase phosphorylation site. (modified after [24, 31])
Classification of sensor kinases into families or groups is difficult given the large vari-
ation in sequence and 3D-structure. Grebe and co-workers grouped the histidine kinases
in 11 different families, based on sequence homologies in their different domains [27]. The
kinases contain six different amino acid motifs (called the H, X, N, D, F and G box),
which have a high degree of conservation between different sensors. Additionally, sensors
of certain kinase subfamilies have the tendency to group with regulators from a specific
RR subfamily (see below, section 1.2.2) [27], indicating co-evolution of the two proteins.
This classification of bacterial sensors is strictly based on sequence data, neglecting any
functional properties of the kinases. Therefore, Mascher and colleagues suggested to group
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histidine kinases based on domain architecture and topology, which leads to a classification
related to the sensor function [23]. The most common design of kinases includes a sensing
domain exposed to the periplasmic space, interacting directly or indirectly with extracel-
lular signals. Those sensors are typically involved in the sensing of nutrients or soluble
substances from the cellular environment. The second largest class are kinases that sense
signals from the cytoplasm. They are either anchored to the cytoplasmic membrane or
are soluble proteins, detecting exclusively cytoplasmic solutes or signals from metabolic or
developmental processes in the cell. A third class of kinases detect membrane-associated
or membrane interface signals like turgor pressure, mechanical stress and electrochemical
gradients. For theses sensors, stimulus perception is performed by the membrane spanning
helices or a combination of one transmembrane helix and one cytoplasmic domain at the
N-terminus. One exception from the usual kinase construction is the E. coli citrate sensor
CitA, which contains one periplasmic and one cytosolic sensor domain [32], resulting from
domain duplication during evolution of the protein.
There are 14 different types of sensor domains [5]. About a third of all sensors use
a PAS 3D-structure (Per-ARNT-Sim) as sensory domain [24], formed by a five-stranded
β-sheet and five α-helices [33, 34]. PAS domains are a universal signaling structure which
are widespread in biology [35], sensing a variety of environmental cues. Interestingly, they
show only conservation on structural level but not within their amino acid sequence [36].
The sensing domain is connected to a cytoplasmic autokinase domain by a membrane
spanning linker region. Transmembrane domains are found in the vast majority (∼83 %)
of sensor kinases [37] in numbers up to 20 TM regions per protein [23]. The autokinase do-
main consists of a long α-hairpin (DHp domain), responsible for dimerization and histidine
phosphotransfer (Figure 1.3). Two DHp domains form a four-helix bundle via the dimer-
ization interface. Additionally, the DHp domain contains a conserved histidine residue,
which acts as phosphorylatable target in the first step of the phosphotransfer reaction.
The C-terminal end of the sensor kinase is formed by the globular catalytic and ATP bind-
ing domain (CA), which is connected to the DHp domain via a short linker. ATP binding
at the CA domain requires the presence of Mg2+ as a bivalent cofactor [38]. Most histidine
kinases are thought to function as dimers, and there is much structural and biochemical
evidence to support this assertion [39, 40]. Nevertheless, the majority of experiments are
derived in vitro so far [41, 42, 43], meaning that a systematic investigation has yet to be
performed in living cells. This is especially important, because the existence of monomeric
sensor kinases was reported by Fabret and colleagues for Bacillus subtilis [44], emphasizing
the variations in design principles within prokaryotic two-component sensors.
Biochemically, histidine kinases catalyze three different kinds of phosphotransfer re-
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actions: (i) their own autophosphorylation (phosphotransfer from ATP to the histidine
residue), (ii) transphosphorylation from His∼P towards an Asp residue of the response
regulator and (iii) dephosphorylation of the response regulator Asp residue [13].
(i) Autophosphorylation: HK-His + ATP ! HK-His∼P + ADP
(ii) Phosphotransfer: HK-His∼P + RR-Asp ! HK-His + RR-Asp∼P
(iii) Dephosphorylation: RR-Asp∼P + H2O ! RR-Asp + Pi
Autophosphoralytion within a kinase dimer was long believed to take place exclusively
in trans, meaning that the phosphoryl group of ATP bound to one monomer is used to
phosphorylate the His residue of the other monomer. This has been shown experimentally
for the sensors AtoS [45], EnvZ [46], KdpD [41], NRII [47] and the non-canonical kinase
CheA [48, 49]. Nevertheless, recent experiments on a sensor kinase from Thermotoga
maritima showed autophosphorylation within the same monomer [50], hinting to at least
one exception of the paradigm assumed so far.
To ensure a proper performance of signal processing and a return to the basic ´off´state
of the pathway, cells have to limit the response temporarily. One possibility to achieve
this is to limit the half-live of a phosphorylated protein residue. Experiments showed that
the half-lives of phosphorylated kinases is not that different independent of the kind of
signaling pathway they are involved in. They range from about 30 to 90 minutes for the
full-length proteins investigated [51, 52], and it seems that the temporal adjustment in
signaling is rather performed through half-live of the response regulator phosphorylation
(see below, section 1.2.2).
1.2.2 Response regulators
The second protein involved in TCS signal transduction is called the response regulator
(RR). Response regulators, as histidine kinases, exhibit a modular architecture harbouring
two different domains, a highly conserved N-terminal receiver and a variable C-terminal
effector (output) domain. This modularity in design allows for a perfect adaptation to the
needs of different regulatory mechanisms. A structural overview of the response regulator
domain organization and effector domain distribution is shown in Figure 1.4.
Response regulators connect the sensor kinase with a downstream target inside the cell.
This is in most cases a promotor sequence, as the majority (63 %) of RRs function as
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transcription factors with a DNA binding domain [15]. E. coli has a high number of
response regulators that bind DNA, 27 out of 32 control gene expression, three contain
a receiver domain, only and two include a unique output domain [5, 12]. Based on their
DNA binding domains, RRs are grouped in three major families [53], OmpR, NarL and
NtrC, with OmpR being the most abundant family in E. coli with 14 members (Table 1.1).
Nevertheless, there are some exceptions to the prototypical design principle. Some RRs
have a enzymatic subunit as C-terminal effectors like the methylesterase CheB from the E.
coli chemotaxis pathway [54] or the cAMP phosphodiesterase from Dictyostelium [55, 56].
About 15 % of bacterial and 50 % of archaeal response regulators lacks the effector domain
completely[57], for example CheY from chemotaxis [15] or the sporulation factor Spo0F
from B. subtilis [58, 59].
The N-terminal receiver domain (REC) functions as a phosphorylation-mediated switch.
Their structure contains a five-stranded parallel β-sheet, which is sorrounded by five α-
helices [60, 61] as shown in Figure 1.4a. The REC domain is involved in phosphorylation
through the cognate sensor via using a conserved Asp residue, generating a high energy
acyl phosphate. Subsequently this binding energy is used to drive a conformational change
affecting a large surface of the REC domain, shifting the equilibrium from one state to an-
other, usually inactive to active. This switching subsequently controls the activity of the
downstream effector domain of the regulator, with a mechanism similar to the energy cou-
pled conformational change in P-type ion-translocating ATPases [60]. The REC domain
is able to perform two kinds of enzymatic reactions, phophotransfer from the kinase and
autodephosphorylation. The ability for phosphotransfer has been shown experimentally
by adding small phosphodonor molecules like acetyl phosphate or carbamoyl phosphate to
regulators, phosphorylating the Asp residue independent of the presence of a kinase [62].
Nevertheless, the phosphorylation rate of a regulator through a kinase is faster than the
rate of autophosphoralytion [63, 64], ensuring a high degree of signaling specificity in vivo.
The intrinsic ability of autodephosphorylation serves to limit the lifetime of the elicited
response after a signaling event, and is therefore a critical step in the signal transmission.
There has been a wide range of dephosphorylation rates reported, ranging from 0.28 s-1
for CheY6 from Rhodobacter sphaeroides [65] up to 0.25 week-1 for RedF from Myxococ-
cus xanthus [66]. These huge differences represent the different timescales of the single
pathways they are involved in, ranging from fast processes like chemotactic sensing to
regulation of developmental processes in slow growing bacteria. As the half-live of phos-
phorylated kinases is relatively stable and conserved between sensors (see section 1.2.1),
temporal adjustments of two-component signaling pathways take place at the response
regulator level.
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In many two-component regulators (e.g. NtrC∼P and CheY∼P), dephosphorylation
is performed through the phosphatase activity of other proteins. Mechanistically, rather
the intrinsic ability of the regulator to dephosphorylate is stimulated instead of direct
dephosphorylation performed by the auxiliary phosphatase [67, 68, 69].
a
b
E!ector domains
REC
Figure 1.4: 3D structures of different response regulator domains.(a) The active and inactive receiver domain
structure (REC) from E. coli PhoB shown in green and blue, respectively. Sorrounding α-helices
are numbered and switching residues are coloured in red. BeF3 (orange) substitutes ATP as
structural analogue for crystallization. (b) Distribution of functional classes among the effector
domains of different RR families. Family names are shown in colour beneath the bar, and for
every family a representative 3D structure is shown using the same colour coding. (modified after
[24])
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Effector domains within response regulators are quite diverse [13], even within a single
family (see Figure 1.4b for details). The members of the OmpR family for example define
a subclass of winged-helix transcription factors. Thereby, the protein fold is structurally
conserved within the family, forming a helix interacting with the major groove of the
DNA and the adjacent wings interacting with the minor groove [70, 15]. Regulators of
the NarL family are characterized by a four-helix DNA binding domain [71], containing a
typical helix-turn-helix motif. The third major response regulator family, NtrC, represents
structurally the most diverse group, with two domains forming the effector part: an ATPase
domain and a helix-turn-helix DNA binding motif [72, 73, 74].
1.3 Signal processing in two-component systems
Despite the classical linear pathway design (Figure 1.5a), there is some complexity in the
regulatory circuits of two-component systems via branched pathways [75]. For example bac-
terial chemotaxis is a ´one-to-many´ pathway (Figure 1.5b), where a single kinase CheA
phosphorylates different response regulators CheY and CheB competitively [76, 77, 78]. An
exemplification of a ´many-to-one´ architecture is the quorum sensing signaling pathway
from the marine bacterium Vibrio harveyi (Figure 1.5c). In this network, three different
hybrid kinases (LuxN, LuxQ and CqsS), respond to different autoinducers and converge
information via phosphorylation of the RR protein LuxU to integrate three different au-
toinducer signals into one pathway [9]. Another example is the sporulation phosphorelay
of B. subtilis [79], where the four kinases KinA-D phosphorylate the regulator Spo0F, the
first part of a signaling cascade switching between sporulation or the entry into stationary
phase. It should be mentioned that these two cases, depending on the literature, are some-
times already classified as cross-talk or cross-regulation, as interactions take place between
different pathways.
Given the large number of TCS present inside a single bacterial cell and their structural
and functional similarities, a major question is the specificity of the performed signaling.
On the one hand, the organism has to ensure the proper isolation of the single cascades
from one another. This isolation prevents detrimental interactions between the different
systems which could lead to a disturbance in information processing inside the cell. On
the other hand, some degree of interactions between different pathways would enable cells
to integrate information from different sources, similar to the mentioned ´many-to-one´
and ´one-to-many´ pathways. This could provide another layer of information processing
on top of the single cascades.
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Figure 1.5: Signaling pathway architectures. (a) Prototypical TCS pathway architecture with one
kinase acting on a single response regulator (RR). (b) One-to-many pathway; one histidine
kinase phosphorylates two different RRs. (c) Many-to-one pathway; different histidine ki-
nases phosphorylate the same RR. (d) Connector-mediated pathway. One two-component
system regulates expression of an auxiliary protein (X), which in turn regulates another
two-component system. (modified after [75])
1.3.1 Signaling specificity
Two-component systems exhibit different properties to ensure specificity in signaling. Sen-
sor kinases for example have in vitro the intrinsic ability to distinguish between cognate
and non-cognate substrates. Phosphorylation of the cognate response regulator is thereby
kinetically preferred compared to other proteins. For instance the E. coli kinase NtrB
is more efficient in phoshorylating NtrC than the non-cognate kinase CheA [80], and the
same was shown between EnvZ/CheA and OmpR [81]. Systematic studies performed on
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TCS from E. coli and C. crescentus confirmed a strong in vitro preference of sensors for
their cognate substrate [82, 83, 84]. For example the osmolarity sensor EnvZ is able to
phosphorylate 16 different non-cognate regulators after a timespan of about 60 minutes.
Nevertheless, transphosphorylation of the cognate regulator OmpR takes only 10 seconds,
indicating a kinetic preference between the cognate components [82]. This holds also true
for branched pathways were the kinase shows a similar affinity for both regulators com-
pared to the non-cognates. In B. subtilis the sensor KinA exhibits a 50000 fold higher
preference for the response regulator Spo0F compared to Spo0A [58, 85]. Taken together
these results confirm that kinetic preference is a general feature for signaling specificity of
two-component pathways in different organisms.
Another possibility to guarantee signaling specificity is the competition of response regu-
lators for the kinase, where the cognate outcompetes the non-cognate regulator. For exam-
ple the kinase VanS of the vancomycin resistance pathway of grampositive bacteria is able
to phosphorylate PhoB, with an enhanced rate in the corresponding regulator knockout
for VanR [86, 87]. This effect is even more pronounced in the double knockouts of the non-
cognate proteins (kinase and regulator), and similar results were shown for CpxA/OmpR
and EnvZ/CpxR [84, 88, 89]. This idea is supported by results showing the phosphory-
lation of regulators by the general phosphodonor acetyl-phosphate, which mostly occured
in the sensor knockout, only [90]. It is assumed that the effect of minimizing cross-talk
by response regulator competition is enhanced by the relative low abundance of kinases
compared to regulators, with a ratio of about 1:30 [91, 92, 93, 94, 95]. This robustness
was demonstrated experimentally for the E. coli TCS EnvZ/OmpR, PhoQP and CpxAR
[92, 93, 95, 88]. Additional evidence for this response regulator competition came from
experiments by Ninfa and colleagues, who showed increased cross talk from overexpressed
NtrB on CheY in a CheA knockout strain [80].
The bifunctional property of some kinases also provides an effective mechanism against
cross-talk. Those sensors work as phosphatases for the cognate regulator preventing un-
intended cross-phosphorylation. This was experimentally confirmed for the VanSR and
PhoRB systems mentioned above [86, 87]. Additionally, it was shown that in absence of
the bifunctional kinases cross-talk occured from CreC to PhoB and UhpB to NtrC/PhoR
[96, 97, 98, 99]. Further support comes from computational studies which showed that
bifunctional kinases are more efficient in the suppression of cross-talk than monofunctional
ones [100]. Monofunctional kinases thereby compensate this lack in phosphatase activity
by using additional phosphatases (e.g. CheZ in chemotaxis), which protect those pathways
against detrimental cross-talk [78]. Additionally to intrinsic specifity, the maintainance of a
high level of phosphorylation and dephosphorylation provides insensitivity to disturbances
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from the outer environment [100, 88, 84].
In addition to biochemical parameters, signaling specificity is provided through struc-
tural protein features. Even though the interaction interface between sensors and regulators
exhibit a high degree in structural conservation [24], the amino acid motifs between differ-
ent systems are variable and mediate specificity [101]. This specificity is mediated through
residues located in the cytoplasmic DHp domain of the kinase [102, 103, 104] and the REC
domain of the regulator [105, 106, 107, 108, 109]. By exchanging these residues, specificity
can be rewired to increase cross-talk to a different two-component system [104].
It should be mentioned that there is also an extrinsic property to ensure signaling speci-
ficity, which is spatial organization (for details see section 1.4) as it is accomplished in
eukaryotes. For example the chemotaxis apparatus in R. sphaeroides is organized in two
different kinds of clusters, avoiding the occurence of cross-talk by separate cellular localiza-
tion [110], and the proteins involved in C. crescentus cell cycle regulation PleC and DivJK
guarantee position dependent specificity [111, 112].
1.3.2 Cross-regulation and cross-talk
Some two-component systems undergo cross-regulation, which is executed through auxil-
iary proteins, linking the activities of two different pathways [113]. In this scheme, one
TCS regulates expression of an auxiliary protein, which subsequently controls the activity
of a second system on the kinase or regulator level (Figure 1.5d). Examples are the in-
teractions of the Mg2+ sensing PhoQP paralogues with EvgAS in E. coli [114] or PmrBA
from Salmonella enterica [115, 116]. Also B. subtilis uses auxiliary proteins for regulation.
The competence response regulator ComA thereby activates synthesis of the phosphatase
RapA, which results in down-regulation of the RR Spo0F. Thus, cells do not enter sporula-
tion [117].Taken a step further, direct interactions between different pathways on different
levels would allow even more sophisticated regulation inside microorganisms (Figure 1.6).
There are different levels, where these interactions can take place: On the level of sen-
sor kinases, either via heterodimerization or formation of higher-order signaling complexes
(Figure 1.6a), cross-phosphorylation of a response regulator by a non-cognate kinase (Fig-
ure 1.6b), interactions between regulators, for instance via heterodimerization (Figure 1.6c)
or on the promotor level through regulation by a non-cognate pathway (Figure 1.6d). The
phenomenon of beneficial cross-interactions between different signaling systems is called
cross-talk, and was first suggested by Hellingwerf and colleagues around fifteen years ago
[118, 119]. They proposed that the redundancy in the design of different two-component
systems and their modularity might lead to cross-talk between different pathways.
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Figure 1.6: Cross-talk on different pathway levels.(a) Cross-talk between histidine kinases via com-
plex formation or sensor heterodimerization. (b) Cross-phosphorylation of a non-cognate
response regulator. (RR). (c) Cross-interactions between two individual response regula-
tors via formation of heterodimers. (d) Cross-regulation of gene-expression via response
regulator binding to a non-cognate promotor. Black arrows represent signal transmission
within individual pathways, red arrows represent possible cross-talk.
Furthermore, they argued that bacteria have to respond to the variety of signals they
receive from their environment [120] with an informed decision, forming a sort of ´neural
network´. This could enable bacteria to develop a kind of ´learned behaviour´ [121] by us-
ing some sort of memory [122], as it is already described for bacterial chemotaxis pathways
[123]. Neural networks are defined by four properties: (i) multiple systems have to oper-
ate in parallel, (ii) key network components have to perform logical operations, (iii) basic
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elements are subject to auto-amplification and (iv) cross-talk can occur. Two-component
systems exhibit most of the aforementioned properties. First, different TCS are simulta-
neously expressed in a single cell and work in parallel [124], the organization in signaling
cascades is rather rare [125]. Second, response regulators have two different states (phos-
phorylated and unphosphorylated) during signal transduction, linking them to a binary
(´digital´) operator with an ´on´- and ´off´- state [126]. Additionally, orphan proteins
integrate and distribute signals from different information sources within the cell, working
as ´hubs´ to perform logical operations between pathways [127]. Third, auto-amplification
is a property which is exhibited in some TCS [121].
This leaves the fourth criteria of ´neural network´ , cross-talk. Generally, TCS are wired
to trigger a specific response upon signal reception [128, 60, 15]. Nevertheless, in a variety
of studies performed during the last years cross-talk was observed between different path-
ways. Ninfa and colleagues showed in vitro cross-talk between non-cognate partners, even
though it was 2 to 4 orders of magnitude slower than the cognate phosphorylation reac-
tion [80]. Different in vivo experiments exhibited occurence of cross-talk between different
unrelated systems [80, 129, 130, 131, 132, 84], but it seems that it mostly occured after
the introduction of genetic perturbations [94]. For example the nitrate/nitrite regulation
from E. coli exhibits multiple layers of fine-tuned cross-talk for regulation [133]. Under
anaerobic conditions, nitrate or nitrite is used as electron-acceptor instead of oxygen. Ni-
trate is sensed by the NarXL TCS, nitrite by the NarQP system. Besides to the linear
signaling cascade, NarQ is able to phosphorylate the non cognate regulator NarL in pres-
ence of nitrite (Figure 1.6b), allowing a differential regulation dependent on the available
nitrogen compounds. Additionally, NarL competes with NarP for an overlapping DNA
binding site [134], adding a further layer of cross-talk to the circuit. For B. subtilis, Howell
and colleagues were able to show cross-talk between the phosphate responsive sensor PhoR
and the non-cognate regulator YycF [107, 135]. Systematic in vitro studies searching for
cross-phosphorylation between sensor kinases and non-cognate response regulators were al-
ready performed for all TCS from E. coli [136]. Between all tested interactions, Yamamoto
and colleagues were able to show ∼3 % of trans-phosphorylation between a kinase and a
non-cognate response regulator.
Another example of physiologically relevant cross-talk was described in the pathogen
Pseudomonas aeruginosa for the kinases RetS and GacS, modulating each others activity
[137]. The two sensors thereby form a heterodimeric complex blocking the GacSA pathway
which subsequently leads to acute virulence of P. aeruginosa (Figure 1.6a).
Another place where cross-talk could occur besides protein interactions is at the tran-
scriptional level. This would allow the integration of signals sensed by different pathways
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via the expression of a certain set of genes (Figure 1.6d). For example, in S. enterica the
two response regulators PmrA and RcsB act on genes involved in regulation of the outer-
membrane lipopolysaccharide (LPS) composition [138, 139]. Another case has been found
in E. coli, where the two RR OmpR and CpxR directly regulate the same genes [140, 141].
Because the knowledge of signaling partners is important for understanding of the overall
signaling netwerk architecture [142], several attempts have been made to predict candidates
of cross-talking partners within the group of two-component proteins by using sequence
data. The underlying principle is to identify amino acid residues within interaction do-
mains of potential interacting protein pairs (in this case kinases and regulators). Li and
colleagues searched for residues which are variable between paralogue proteins, but con-
served between orthologues (for both HK and RR). Using that method they were able to
identify residues that confer interaction specificity [143]. Based on amino acid alignments,
Burger et al. rated the interaction possibility using a co-variation analysis algorithm [127].
They were able to reconstruct in silico the TCS pathways for all currently sequenced bac-
teria, proofing the feasibility of their attempt also for prediction of possible interaction
partners. They were able to identify two different groups of TCS proteins, cognates and
orphans which form rather isolated groups of signaling proteins. Both groups share the
same evolutionary origin, but evolved independently on a shorter timescale [144]. Cog-
nates represent the vast majority, and their characteristic is the organization of the two
interation partners within one operon. Orphans represent proteins lying isolated from
their interaction partner on the genome, and ∼10 % of them are so-called ´hubs´. They
work as nodes in the signaling circuit that interact with multiple proteins and integrate
and distribute signals. Furthermore, Burger and colleagues found out that occurence of
cross-talk between cognates is low, but it increases with the number of pairs present in
the organism. A more recent study rated the preference of directly interacting amino acid
residues between TCS proteins which can be explained by biochemical interactions [142].
This work is again based on residue co-evolution and includes data from 769 sequenced
bacterial genomes. Procaccini and co-workers predicted for 15-25 % of all TCS at least one
of the proteins could participate in cross-talk. They tested their prediction using available
experimental data sets and were able to confirm 2 out of 3 in vivo results from B. subtilis
[135, 145] and 6 out of 7 from C. crescentus [102, 82]. For E. coli they identified a lower
amount of cross-talk, namely between CitAB and DcuSR and between CusSR and YedVW.
These predictions were in agreement with in vitro experiments performed earlier [136].
Taken together, these results highlight the potential of a certain degree of in vivo cross-
talk, even though there is a high intrinsic specificity in the wiring of single signaling path-
ways. Nevertheless, a comprehensive general description of two-component pathway de-
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signs seems to be difficult, as for every principle mentioned above only a few examples are
described in detail [75].
1.4 Intracellular localization of signaling proteins
In recent years it became evident that also bacteria are more complex in respect to their
cellular organization than the old view of simple ´bags of enzymes´ , and localization of cel-
lular components plays a significant role in different processes [146]. Similar to eukaryotes,
which use cellular compartimentalization or form scaffolding structures to bring signaling
components together, bacteria make use of higher-order structures [147]. For the compo-
nents of signaling pathways, distinct localization of proteins could ensure functionality of
information processing by promoting enzymatic reactions at specific loci and isolate the
components from detrimental interference with other pathways [148].
B. subtilis for example forms a high-order protein complex called the ´stressosome´,
which localizes to distinct foci in the cytoplasm [149]. This complex integrates a variety of
sensed cues to regulate subsequently ∼150 genes. The soil bacterium Myxococcus xanthus
regulates its motility with regulator proteins specifically localized to the cell poles and
the cell periphery [150, 151, 152]. Thereby the proteins AglZ, FrsZ and RomR control the
direction of movement by regulating the action of type-IV-pili and the A-engine responsible
for M. xanthus´ motility [153, 152, 154].
One of the best studied example of spatial organization in prokaryotes is the chemotaxis
apparatus of E. coli, a non-canonical two-component system. The sensory complexes are
formed by MCPs, the kinase CheA and the adaptor protein CheW, and contain up to
several thousand proteins per cluster [155, 156, 157]. They localize to distinct polar and
lateral clusters at the cytoplasmic membrane [158, 159, 160], and enable the cell to trans-
mit, amplify and integrate the sensed information. Additionally, clustering enhances the
specificity and efficiency of signaling [161]. Such polar chemoreceptor clusters have also
been described for a variety of other bacteria and archaea [162]. A bit more complex is
the design of R. sphaeroides´ chemotaxis apparatus, which contains two different chemo-
tactic clusters, one at the poles and one at the cytoplasmic membrane at mid-cell [163].
Both systems have a different protein composition allowing a more elaborate processing of
extracellular signals.
For canonical histidine kinases so far there are only a few studies describing their local-
ization inside cells. Extensive studies have been performed on the kinases involved in the
cell cycle regulation of C. crescentus, which provide a regulation cascade establishing the
cellular asymmetry for differentiation into morphological different cell types [164, 111, 112].
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Before cell division, the kinase DivJ and the kinase/phosphatase PleC are distributed to
different cell poles, allowing different action on the response regulator DivK dependent
on the spatial localization [165]. Additionally, the global regulator CtrA (located at the
stalked pole) the ClpXP protease complex and the cyclic-di-GMP sensor PopA play a role
in the cells differentiation process [166]. The information about the poles identity comes
thereby from interactions with the pole-specific protein TipN and with MreB, the bacterial
actin-homologue [167]. Polar kinase localization has also been observerd for cells which
do not show morphological differentiation, for example for the two E. coli sensor kinases
CitA and DcuS [168, 169]. They show distinct localization forming polar spots similar to
those found for MCPs from chemotaxis [160]. Thereby, DcuS localization is independent
from presence or absence of MCPs, indicating no direct connection of the two systems.
DcuS spot formation is independent of the protein expression level, but seems to increase
with the concentration of Fumarate, the stimulus of the sensor. The reason for this clus-
tered localization remains unclear. As both CitA and DcuS are involved in metabolic
processes for sensing of C4-dicarboxylates [170, 171], a positive influence from clustering
on the signal processing performance is not obvious for these systems. In P. aeruginosa
polar localization of the histidine kinase PilS has been shown, which is involved in sensing
required for type IV pilus synthesis [172]. A similar localization has been described for
proteins involved in the c-di-GMP signaling cascade in E. coli, where localization provides
a higher degree of specificity in infomation processing [8]. What the mechanism of the
polar protein localization in bacteria is exactly remains elusive to date, but it seems that
the different lipid composition at the cell poles and/or the changed membrane curvature
play an important role[173, 174, 175].For response regulators of two-component systems
very little specific localization has been found thus far. Sourjik and colleagues showed that
the regulator CheY from E. coli chemotaxis co-localizes with the chemotaxis clusters [159].
It has been shown for EnvZ/OmpR, that for a sufficient high level of kinase expression
the response regulator forms a complex with the sensor at the cell periphery [92, 176], and
similar localization has been shown for the regulator PhoP [177]. However, the majority
of regulators are thought to exhibit a homogenous cytoplasmic distribution pattern [178].
Even though there are some studies performed on the localization pattern of orthodox
TCS components, a comprehensive characterization in a bacterial cell remains elusive.
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1.5 Fluorescence microscopy
Fluorescence microscopy has become an important tool in modern cell and molecular bi-
ology, since it allows investigations of living systems through providing high spatial and
temporal resolution [148]. It gives a powerful method to study the localization of cellular
components and their dynamics in vivo on a single-cell level. Fluorescence microscopy
relies on the usage of chromophores. These are molecules that are excitable with light of
a certain wavelength, which induces spontaneous emission of light at a longer wavelength
[179].
Such chromophores as fluorescent dyes are useful for the labelling of cellular components,
but their application to bacterial systems is rather limited. Because of the low permeability
of bacterial membranes the dye is not taken up into the cytoplasm. The labelling using
immunofluorescence can only be performed on extracellular proteins or using permeabilized
cells, making it not usable for intracellular applications. Quantom dots are another method
for protein labelling, but their relatively large size exclude their usage from prokaryotes. For
bacteria the method of choice to noninvasively label proteins is to fuse them to fluorescent
proteins (FP).
1.5.1 Fluorescent proteins
Dependent on the spectral properties (´colour´) or other parameters like brightness or
photostability, there is up to date a wide range of either natural occuring FPs like the
green fluorescent protein GFP [180, 181], dsRed [182] or their artificially engineered variants
[183, 184]. One major advantage is their non-cytotoxicity for prokaryotes, and that they
are highly specific for protein labelling in vivo. Additionally, fusions to proteins of interest
provide a readout for their localization and abundance inside cells as fluorescence intensity
is a direct marker for the strength of protein expression [180]. This can furthermore be
used to quantify the strength of promotor activities [185]. One main drawback of using FPs
is the relatively large size of the formed β-barrel (2.4 by 4 nM), which might lead to steric
hindrance within the labelled protein or interactions with other cellular components [184].
Another limitation is that distance of fluorophores lowers FRET efficiency (see below for
details), which is to a certain degree the case for the two fluorescent proteins.
In this work different variations of FPs were used. After some initial tests of new YFP,
CFP and mRFP variants [186, 187, 188, 189] in our FRET setup (see below and sections
2.12.3, 3.1), protein fusions to histidine kinases and response regulators were constructed
using eyfpA206K and ecfpA206K[190]. This variants harbour a point mutation at amino acid
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position 206 changing Alanine to Lysine, which prevents dimerization of the fluorophores.
This circumvents any artifacts due to their oligomeric state in the FRET measurements
or the protein localization studies. The used promotor fusions from the E. coli promotor
collection [185] contain the engineered gfpmut2 protein, a bright and fast folding green
fluorescent protein optimized for flow cytometry applications [191].
1.5.2 Fluorescence Resonance Energy Transfer (FRET)
The underlying principle of FRET (Fluorescence or Förster Resonance Energy Transfer)
[192] is a distance-dependent non-radiative energy transfer between two different fluorescent
molecules, acting as donor and receptor, respectively (Figure 1.7a).
CFP YFP
a                  b
Figure 1.7: FRET principles. (a) Illustration showing FRET (red arrow) between two proteins labelled
with YFP and CFP, respectively. (b) Curves showing the overlap between the CFP emission
(blue line) and the YFP excitation (orange line) spectra. Data taken from the Tsien lab
homepage (http://www.tsienlab.ucsd.edu/).
One requirement therefore is the overlap between the donor emission- and the acceptor
excitation-spectrum as shown for YFP and CFP in Figure 1.7b.
FRET methods allow to investigate non-invasive interactions between fluorescently la-
beled proteins inside living cells [193]. The strength of FRET assays lies in the possibility
to quantify (transient) in vivo interactions in real time, making it especially suitable to
study protein-protein interactions or conformational changes of proteins involved in signal
transduction networks [194, 148].
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The efficiency of energy transfer between fluorescently labelled proteins organized in
complexes depends on the distance between the two labelled molecules, and can be de-
scribed as
EFRET =
R60
R6 +R60
(1.1)
with R as distance between the centers of the used fluorophores and R0 beeing the Förster
radius [192]. At this distance the energy transfer between donor and acceptor has an
efficiency of 50 %. R0 thereby can be calculated using the overlap between the emission
spectra of donor and acceptor, the orientation of the two fluorophores and the properties of
the surrounding medium [195]. If the fluorophore is attached to a protein of interest using
a flexible peptide linker (allowing its free rotation), the Förster radius R0 is about 4.9 nm
[196, 181]. This leads, taking the steep FRET dependence upon distance into account, to
the conclusion that above a distance of about 10 nm no FRET can occur anymore [194].
Given this the occurence of false positive results using an in vivo FRET assay for protein-
protein interactions are neglectable. Nevertheless, if for structural reasons the donor and
acceptor fluorophore are more than 10 nm apart, false negative results might occur. To
overcome this limitation it is advisable, if possible, to test combinations of different protein
fusions, e.g. N- and C-terminal, in all possible combinations.
1.6 Aims of the current work
As the most important signal transduction pathways in prokaryotes and lower eukaryotes,
two component signaling systems have been extensively investigated during the last thirty
years. Members have been identified in nearly all bacterial and archaeal genomes, and a
lot is known about the molecular details involved in signal transmission. Despite these
progresses in the understanding of two-component systems, quite a few open questions
still remain to be solved. For instance, to date little is known about the interconnection
between different pathways inside a living bacterial cell. Additionally, a systematic study
of spatial organization of the involved proteins is lacking.
To address these questions, we studied systematically in vivo the intracellular orga-
nization of proteins involved in two-component signaling pathways in Escherichia coli.
Additionally, we were interested in possible interconnections between individual signal
transduction cascades on different levels. Therefore we constructed a comprehensive li-
brary of histidine kinases and response regulators with fluorescent protein fusions. Fur-
thermore, fluorescent transcriptional reporters of promotors regulated by two-component
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systems have been used or constructed to investigate effects on gene expression. Testing
the fluorescent fusions with such fluorescence techniques as imaging, flow cytometry, ac-
ceptor photobleaching and stimulus dependent FRET provided us with insights into the
spatial organization and complex formations of the sensors. Furthermore, possible physi-
cal changes in response to various stimuli have been studied, and the effects of stimuli on
the resulting transcriptional response were characterized. The obtained results provided
new insights into spatial organization within and communication between different two-
component systems in terms of information exchange or integration at different molecular
levels. The 30 two-component systems present in E. coli represent most of the existing
sensory kinase families. Hence, the results of this study broaden the understanding of
cell signaling performed in other bacteria and even in lower eukaryotes outside the animal
kingdom.
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2 Materials and methods
2.1 Chemicals and consumables
All chemicals and consumables used in this work are listed in Table 6.6 in the Appendix.
2.1.1 Media and plates
Luria broth (LB) plates
10 g Tryptone
5 g Yeast extract
5 g NaCl
15 g Agar
Added ddH2O up to a total volume of 1 L and adjusted to pH 7 using NaOH. Where
appropriate, antibiotics were added to the following final concentrations: ampicillin 100
mg/mL, kanamycin 50 mg/mL and chloramphenicol 34 mg/mL.
LB media
10 g Bacto tryptone
5 g Bacto yeast extract
5 g NaCl
Added ddH2O up to a total volume of 1 L and adjusted to pH 7 using NaOH.
Tryptone broth (TB) media
10 g Bacto tryptone
5 g NaCl
Added ddH2O up to a total volume of 1 L and adjusted to pH 7 using NaOH.
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5x Minimal A stock solution
10 g (NH4)2SO4
45 g KH2PO4
105 g K2HPO4
5 g Na-Citrate · H2O
Added ddH2O up to a total volume of 2 L and autoclaved.
Minimal A media
100 mL 5x Minimal A stock solution
0.5 mL 1 M MgSO4
5 mL 20 % carbon source (glucose or glycerol)
25 mL 2 % Casaminoacids
Added ddH2O up to a total volume of 500 mL.
2.1.2 Buffers and solutions
TAE buffer for DNA gel electrophoresis
242 g Tris base
57.1 g Glacial acetic acid
100 mL 0.5 M EDTA (pH 8)
Added ddH2O up to a total volume of 1 L.
Tethering buffer
100 mL 0.1 M KPO4
200 µL 0.5 M EDTA
13.4 mL 5 M NaCl
100 µL 10 M Methionine
100 µL 10 M Lactic acid
Added ddH2O up to a total volume of 1 L and adjusted to pH 7 using NaOH.
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Phosphate buffer
100 mL 0.1 M KPO4
13.4 mL 5 M NaCl
100 µL 10 M Lactic acid
Added ddH2O up to a total volume of 1 L and adjusted to pH 7 using NaOH.
6x DNA gel loading buffer
30 % (v/v) Glycerol
0.25 % (w/v) Bromophenol blue
0.25 % (w/v) Xylene cyanol
4x SDS Laemmli buffer
8 % SDS
40 % Glycerol
20 % β-mercaptoethanol
0.008 % Bromphenol blue
0.34 M Tris
Adjust pH to 6.8.
10x SDS gel running buffer
144.2 g Glycine
30.3 g Tris base
10 g SDS
Added ddH2O up to a total volume of 1 L.
12 % SDS resolving gel
1.7 mL ddH2O
2 mL 30 % Acrylamide mix
1.3 mL 1.5 M Tris (pH 8.8)
50 µL 10 % SDS
50 µL 10 % APS
2 µL TEMED
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5 % SDS stacking gel
0.68 mL ddH2O
0.17 mL 30 % Acrylamide mix
0.13 mL 1.5 M Tris (pH 6.8)
10 µL 10 % SDS
10 µL 10 % APS
1 µL TEMED
Western blot transfer buffer
2.9 g Glycine
5.8 g Tris base
3.8 g SDS
200 mL Methanol
Added ddH2O up to a total volume of 1 L.
10x TBS buffer
88 g NaCl
12.1 g Tris base
Added ddH2O up to a total volume of 1 L and adjusted pH to 7.4.
1 kb plus DNA ladder
20 µL DNA ladder stock (Invitrogen)
40 µL 10x DNA gel loading buffer
180 µL ddH2O
Antibiotics
Ampicillin 100 mg/mL in ddH2O
Chloramphenicol 34 mg/mL in 70 % Ethanol
Kanamycin 50 mg/mL in ddH2O
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Inducers
L-arabinose 10 % in ddH2O
Isopropyl-β-D-thiogalactopyranosid (IPTG) 0.1 M in ddH2O
TSS solution
5 g Polyethyleneglycol (PEG) 8000
0.3 g MgCl2 · H2O
2.5 mL DMSO
Added LB medium up to a total volume of 50 mL and filter sterilized.
2.1.3 Reaction kits
• NucleoSpin Plasmid Kit, Macherey-Nagel, Düren
• QIAprep Spin Miniprep Kit 250, Qiagen, Hilden
• QIAquick Gel Extraction Kit, Qiagen, Hilden
Kits were used according to the manufacturer´s protocol.
2.1.4 Antibodies
For analysis of protein degradation using immunoblotting GFP-specific monoclonal mouse
antibody JL-8 (BD Biosciences, Heidelberg) and fluorescently labelled anti-mouse IgG
goat antibody IRDye™700DX (Rockland) were used as primary and secondary antibody,
respectively.
2.2 Bacterial strains
Table 6.5 in Appendix shows a list of all bacterial strains used in this study. All strains
are derivatives of the Escherichia coli K-12 strains MG 1655 [11] or BW25113 [197] in case
of the Keio collection, where strains containing knockouts of either the kinase or response
regulator were obtained from [198]. All knockout strains were tested using PCR for correct
insertion of the kanamycin cassette using gene-specific primers (see Table 6.3). Where
needed, the integrated kan-cassette was removed using the plasmid pCP20 [199]. This
plasmid shows temperature-sensitive replication and thermal induction of FLP synthesis.
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Cells were co-transformed with pCP20 and grown over night at 30 °C on a LB plate with
ampicillin to induce FLP synthesis, leading to a flipout of the kan-cassette. To remove the
plasmid, cells were incubated on LB plates at least two times over night at 42 °C. Selection
for positive clones (e.g. loss of kanamycin resistance) finally was performed using different
LB plates containing different antibiotics at 37 °C over night.
2.3 Plasmids
Table 6.1 in Appendix shows a list of all plasmids used in this study.
pES plasmids harbouring fluorescent protein fusions were constructed during this study
using standard molecular cloning techniques described as below (for details see section
3.2). PCR products were cloned into either pDK112 (YFP fusions) or pDK113 (CFP fu-
sions) vectors creating an C-terminal tagged fusion protein. For both plasmids a CCATG-
GAATTCGAGCTCGGATCCGGAGGTGGA sequence is placed in front of the gene cod-
ing for monomeric eyfpA206K (pDK112) or ecfpA206K (pDK113) [190], which allows cloning
using the restriction sites NcoI and BamHI and encodes for a GSGGG linker in front of
the fluorophore. CFP fusions were subsequently transferred into the pBAD33 expression
plasmid [200] using restriction sites SpeI (compatible to XbaI) and HindIII. For the fluo-
rescent protein test, additionally CheY-FP fusions were constructed using fusion PCR as
described in Sourjik and Berg 2000 [159]. YPet/CyPet [189], Venus/Cerulean [186, 187]
and mCherry [188] were used as fluorophores fused to CheY.
pVS, pAM, pDK and pAE plasmids were a personal gift from Victor Sourjik, Anette
Müller, David Kentner and Andreas Ernst, respectively (lab stocks). Plasmids pCP20
and pACBSR were taken from the lab stock. Promotor GFP fusions were obtained from
the E. coli Promotor Collection [185]. The modified pKD13 plasmid for chromosomal
YFP-fusions was a personal gift from Juliane Winkler and Axel Mogk.
2.4 Primers
Table 6.3 in Appendix shows a list of all primers used during this study. All primers
were synthesized at MWG Biotech (Martinsried, Germany). VIC and DK primers were a
personal gift from Victor Sourjik and David Kentner, respectively (lab stocks).
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2.5 Molecular cloning
2.5.1 Polymerase Chain Reaction (PCR)
5 µL Genomic template DNA*
8 µL 10x PCR buffer
0.3 µL dNTP Stock (1.25 mM)
0.3 µL sense primer
0.3 µL reverse primer
36.1 µL polymerase
add to 50 µL ddH2O
* For amplification of wildtype genes cells of a single colony (from a freshly streaked LB-
plate) were used as template DNA.
PCR cycle:
5 min 95 °C
30 sec 95 °C
45 sec 55 °C (variable, depending on melting temperature of used primers) 25 cycles
1 min 72 °C (variable, depending on length of fragment and used polymerase)
10 min 72 °C
PCR reactions were performed using T gradient and T professional thermocycler (Biome-
tra). Resulting fragments were separated and analyzed by electrophoresis using a 1 %
agarose gel consisting of 0.5 g agarose in 50 mL TAE buffer and 0.5 µL Ethidium bromide.
Gel extraction and PCR purification was carried out using the QIAquick Kit (listed in
2.1.2).
2.5.2 Restriction digest
Enzymes used for restriction digests were AflII, AflIII, BamHI, BglII, BspHI, EcoRI,
EcoRV, HindIII, HpaI, KpnI, NcoI, NdeI, NheI, SpeI, XbaI and XhoI from Fermentas or
New England Biolabs.
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Preparative restriction digest was performed using
10 µL Template DNA
3 µL 10x Restriction buffer
1 µL of each restriction enzyme (if same activity in double digestion)
15 µL ddH2O
Mixture was incubated for 2-3 h at 37 °C.
Analytical restriction digest was performed using
5 µL Template DNA
2 µL 10x Restriction buffer
0.5 µL of each restriction enzyme (if same activity in double digestion)
12 µL ddH2O
Mixture was incubated for 1-2 h at 37 °C.
2.5.3 Ligation
Ligation of DNA fragments was performed using enzymes from Fermentas or New England
Biolabs using the following protocol:
3-5 µL Insert DNA
1 µL Vector DNA
2 µL 5x ligation buffer
1 µL T4 DNA ligase
1-3 µL ddH2O
Mixture was incubated either over night at 16 °C or for 10 min at RT followed by 16 h at
4 °C.
2.5.4 Competent cells
For producing competent cells, three different procedures were used during this work: the
“classical” chemical approach, a slight variation of this method for electrocompetent cells
and the one-step method (see section 2.5.5) developed by Chung and co-workers [201].
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For the chemical method, 1 mL cells of an LB overnight culture were diluted into 100
mL fresh LB media and grown at 37 °C to an OD600 = 0.7. After harvesting the cells for 5
min at 4000 rpm, the pellet was resuspended in 25 mL chilled 0.1 M MgCl2 and incubated
on ice for 30 min. In the next step the cells were centrifugated 5 min at 4000 rpm and
the pellet was resuspended in 50 mL ice-cold 0.1 M CaCl2 , centrifugation was performed
again. Next cells were resuspended in 3 mL 0.1 M CaCl2+18 % glycerol and incubated at
4 °C for two hours. Finally competent cells were aliquoted and frozen at -80 °C.
To produce competent E. coli cells for electroporation, first cells were transformed
with the plasmid pKD46, harbouring the λ-red genes necessary for homologues recom-
bination [197] and selected on solid LB+Amp plates over night. From a single colony, 5
mL LB+Amp overnight culture were inoculated and grown at 30 °C. 500 mL LB+Amp
were inoculated using 5 mL overnight culture and shaken at 30 °C to an OD600 = 0.7. Cells
were incubated on ice for 30 minutes. After harvesting the cells for 20 min at 4 °C and
2500 rpm, the pellet was resuspended in 500 mL 10 % glycerol. This step was repeated
twice using 250 mL and 100 ml of 10 % glycerol for resuspending the cells, respectively.
Finally, the pellet was resuspended in 3 mL 10 % glycerol and aliquoted to samples of 100
µL. Aliquots were immediately shock-frozen in liquid nitrogen and stored at -80 °C until
their usage for electroporation.
2.5.5 One-step preparation of competent cells
Chung et al. [201] invented a method to make bacterial cells competent without the need
of multiple washing and resuspending steps as performed in the “classical” approach. They
developed a special transformation and storage solution (TSS), which allows to combine
the chemical treatment of the cells for competence and transformation. Given this, the
method is much faster to apply and especially feasible if only a small amount of competent
cells is needed. In this work, the method was mainly applied to transform DNA into strains
from the Keio collection [198].
1 mL cells of a LB overnight culture were diluted in 10 mL fresh LB medium an grown
at 37 °C to an OD600 = 0.3-0.4. 1 mL of the culture was transferred into a chilled reaction
tube and harvested using a table top centrifuge at 8000 rpm for 1 minute. The supernatant
was removed and the pellet was resuspended in 100 µL ice-cold TSS using the pipet-tip.
1-2 µL plasmid DNA was added and gently mixed using the pipet-tip. Cells were stored
on ice for 30-60 minutes. Then 900 µL LB were added and the suspension was incubated
at 37 °C and 600 rpm for 1 hour. Finally, cells were harvested at 8000 rpm for 1 min,
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the supernatant was reduced to 100 µL, the pellet resuspended and the volume plated on
LB agar plates (with antibiotics where appropriate). Plates were incubated over night at
37 °C.
2.5.6 Transformation of chemical competent cells
For transformation, 1-2 µL of plasmid DNA and 50 µL of thawed competent cells were
briefly mixed using the pipet-tip and incubated at 4 °C for 30 min. After applying a heat
shock at 42 °C for 45 sec, cells were stored on ice again for another 10 min. Subsequently
1 mL LB medium was added and cells were shaken at 650 rpm and 37 °C for 45-60 min.
After a centrifugation step at 8000 rpm for 1 minute, the supernatant was reduced to
100 µL, the pellet was resuspended and plated on LB agar plates (with antibiotics where
appropriate). Plates were incubated over night at 37 °C.
2.5.7 Transformation using electroporation
Before performing transformation, electroporation cuvettes were stored on ice and LB me-
dia was heated to 37 °C. 100 µL of in ice thawed electrocompetent cells was mixed with
100-200 ng of linearized DNA and gently mixed using the pipet tip. The mixture was
transferred into the cuvettes and they were dryed before loading into the electroporator.
The electric shock was applied with a current of 2.5 kV for 5.2 ms and immediately after-
wards 1 mL of pre-warmed LB was added to the cells. The solution was incubated at 37
°C and 350 rpm for 1 hour and plated on LB+kan plates for selection purposes. Plates
were incubated at 37 °C over night.
2.6 Cloning by homologues recombination
To determine the native protein copy number of histidine kinases, chromosomal insertions
of a gene sequence encoding YFP were constructed. These insertions were designed as
shown in Figure 2.1, leading to a sensor-YFP fusion which is under control of the native
promotor. The used method is a variation of the standard protocol for homologues re-
combination in E. coli [197], so called “gene gorging” [202]. A schematic representation is
shown in Figure 2.1. The first step is to modify the plasmid pKD13 by introducing gene
regions homologues to sites flanking the desired insertion locus on the chromosome.
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Figure 2.1: Scheme “gene gorging” method. Detailed methodology is described in the main text.
P1-P4: Primer for homology amplification. FRT: Flp recombination target sites. (modi-
fied after [202, 198])
These 300-500 basepairs long regions were amplified using PCR and inserted into the
plasmid using restriction endonucleases. The resulting plasmid was co-transformed with
the pACBSR helper plasmid into wt cells using the TSS protocol and grown over night
using LB+CAM+Kan plates. Transformants were incubated 1 mL of LB+CAM+Kan
with 10 µL of arabinose (20 % stock solution) for 9 h at 37 °C. During this step the I-SceI
endonuclease and the λ-Red enzymes are expressed from the helper plasmid and performed
in vivo linearization and final chromosomal insertion of the gene of interest. Positives
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were selected on LB plates with different antibiotics and screened for kan+/cam-/kan--
clones, which only harbour the chromosomal kan cassette. After co-transformation of the
resulting strains with the pCP20 plasmid (TSS protocol) and incubation on LB plates
at 30 °C (removal of the kan-cassette), clones were purified from the pCP20 plasmid by
three rounds of selection on LB plates without antibiotics at 42 °C. The gene gorging
method did not worked in our hands as described, the in vivo insertion failed several
times. Alternatively, we co-transformed the digested homology plasmid DNA into cells
carrying the pKD46 helper plasmid using electroporation. pKD46 carries the λ-Red genes
homologues recombination under control of an arabinose inducible promotor.
2.7 Frozen cell stocks
For long-term storage, cells were inoculated in 5 mL TB medium (plus antibiotics were
appropriate) and grown at 37 °C on a rotary shaker for 16 h. Cells were harvested at
4000 rpm for 7 minutes and resuspended in 1 mL TB+18 % glycerol. The stocks were
briefly stored on ice and frozen at -80 °C.
2.8 Protein degradation analysis
To test the stability of the constructed protein-YFP fusions and identify possible degrada-
tion they were tested using SDS-PAGE and immunoblotting [203, 204]. The used SDS gel
concentrations were 5 % and 12 % for the stacking and resolving gel, respectively.
Protein samples were expressed under the same conditions as used for FRET microscopy,
and 1 mL culture was harvested and immediately shock-frozen in liquid nitrogen. The cell
pellet was resuspended in 85 µL 3x Laemmli buffer and 165 µL H2O, boiled at 95 °C
for 5 minutes, briefly vortexed and boiled for another 5 minutes. The solution was cen-
trifuged 1 minute at 8000 rpm and subsequently 10-15 µL of sample were loaded onto
the SDS gel for separation. 3 µL of protein marker (Pageruler prestained protein lad-
der, Fermentas) was used. Electrophoresis was performed at 150 V (Biorad equipment),
and subsequently samples were transferred onto a Hybond-ECL nitrocellulose membrane
with 0.22 µM pore size (Amersham Biosciences) using a Biometra semi-dry blotting de-
vice. Electrophoresis and immunoblotting was performed according to the manufacturer´s
instructions. Membranes were blocked and hybridized as described before [159]. Used an-
tibodies were a GFP-specific primary monoclonal mouse antibody (JL-8, BD Biosciences;
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dilution 1:5000) and a fluorescently labelled secondary anti-mouse IgG goat antibody
(IRDye™700DX, Rockland; dilution 1:10000). Immunoblot signals were detected using
an infrared LI-COR scanner (Odyssey). The amount of protein degradation was quanti-
fied using the gel analysis function of the public domain software ImageJ 1.40g (Wayne
Rasband, http://rsb.info.nih.gov/ij/).
2.9 Bacterial growth conditions
Cells were grown in either Tryptone broth (TB), Luria broth (LB) or minimal A medium
[205]. Minimal A medium was supplemented with 0.1 % (w/v) casamino acids, 1 mM
MgSO4 and 0.2 % (w/v) glucose or glycerol as carbon source, respectively.
For FRET and FACS experiments cells were grown in TB in a rotary shaker at 34 °C and
275 rpm as described before [159]. Antibiotics ampicillin, kanamycin and chloramphenicol
were added to final concentrations of 100 mg/ml, 35 mg/ml and 50 mg/ml, respectively. All
overnight cultures were diluted 1:100 and grown until OD600 of 0.4–0.5, when appropriate
in the presence of antibiotics and isopropyl b-D-thiogalactoside (IPTG) or arabinose as
inducer. Cells were harvested using centrifugation at 4000 rpm for 5 min, washed and
resuspended in half of the volume phosphate buffer.
Cells for imaging experiments were grown in either LB, TB or minimal A medium and
harvested and washed as described before (without final concentration step).
Cultures for promotor activation experiments were grown in minimal A medium as de-
scribed before, and the stimulus was added to the shaking liquid culture 30-45 minutes
before harvesting.
Before all measurements, samples were stored at 6 °C for about 30 minutes to stop fur-
ther cell growth and protein expression.
2.10 Quantification of protein levels
To determine the mean expression levels of our protein-YFP reporter fusions, we performed
flow cytometry experiments as described earlier [206, 207]. Measurements were performed
on a FACScan (BD Biosciences) equipped with a 488-nm argon laser. FACScan data were
analysed using the CellQuest™ Pro 4.0.1 software (BD Biosciences). In general, between
10000 and 100000 cells were measured per sample and at least one replication in a biolog-
ical independent experiment was performed. Expression of the constructed CFP fusions
was estimated using fluorescence imaging as it was described earlier [207]. Therefore, the
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acquired pictures were quantified by measuring the grey values using the public domain
software ImageJ version 1.40g (Wayne Rasband, http://rsb.info.nih.gov/ij/). The derived
intensities from flow cytometry and imaging were recalculated into absolute protein num-
bers using a calibration with purified YFP and CFP proteins as it was described previously
[207]. In all subsequent experiments, expression levels of protein fusions were adjusted to
a few thousand copies per cell if possible.
2.11 Promotor reporter assay
For most of the investigated TCS no phenotypic readout is available. To verify function-
ality, we performed an assay using promotor activities as indicator for the presence of
upstream signaling events. First, we identified one or few promotors for every TCS, which
are reported to be a downstream targets of the signaling cascade. For all chosen reporters
either transcriptional GFP fusions from the plasmid based GFP-promotor collection [185]
were taken, or we constructed them in a similar fashion using molecular cloning. Wildtype
and certain knockout cells were transformed with the promotor reporters and measured
using flow cytometry (for details see section 2.10).
2.12 Fluorescence microscopy
2.12.1 Imaging
For imaging, bacteria were applied to a thin agarose pad (1 % agarose in tethering buffer)
placed on a glass slide. Fluorescence imaging was performed on a Zeiss AxioImager mi-
croscope equipped with a Zeiss α Plan Fluor 100× 1.45 oil immersion objective, HE YFP
(Excitation BP 500/25; Emission BP 535/30) and HE CFP (Excitation BP 436/25; Emis-
sion BP 480/40) filter sets and a EXFO 120 illumination system (Xcite). Pictures were
acquired using an ORCA AG CCD camera (Hamamatsu). Each experiment was performed
in duplicate on biological independent replicates.
2.12.2 Acceptor photobleaching FRET
Figure 2.2 shows the used microscopy setup for in vivo FRET applications. Acceptor pho-
tobleaching FRET measurements (Figure 2.2a) were performed using a custom-modified
Zeiss Axiovert 200 microscope as described previously [207]. 1 mL of cells expressing
fluorescent protein fusions were concentrated about twentyfold using centrifugation and
applied to a thin agarose pad (1 % agarose in tethering buffer) placed on a glass slide.
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Excitation light from a 75 XBO lamp was attenuated by a neutral-density filter (ND),
passed through a 436/20 band-pass (BP) filter, a 495DCSP dichroic mirror and was
reflected onto the sample by a Z440/532 dual-band beamsplitter (transmission 465-500
and 550-640 nm; reflexion 425-445 and 532 nm). YFP bleaching was performed using a
20 sec pulse from a 532 nm diode laser (Rapp OptoElectronic), which was reflected onto the
sample by the dichroic mirror. The bleached area was narrowed using a diaphragm. CFP
emission passed through a BP 485/40 filter and was measured using a H7421-40 photo-
multiplier (Hamamatsu). For each measured time point, photons per second were counted
over 0.5 s using a PCI-6034E board (National Instruments). The photomultiplier was
controlled using a custom-written routine for LabView 7.1 (National Instruments). CFP
emission was recorded before and after YFP bleaching, and FRET was calculated using
Equation 2.4.
2.12.3 Stimulus dependent FRET
The used microscopy setup is shown in Figure 2.2b. Stimulus-dependent FRET measure-
ments were performed on a custom-modified Zeiss Axiovert 200 microscope as described
previously [207]. 1 mL of cells expressing fluorescent protein fusions were concentrated
about twentyfold using centrifugation and attached to a coverslip coated with poly-L-lysine.
After 15 min of attachment, the coverslip was placed into a custom made flow chamber
(ZMBH inhouse facility) connected to a syringe pump (Harvard Apparatus), which allowed
incubation of cells under a constant flow of phosphate buffer (300 mL/min). Excitation
light passed through a BP 436/20 filter and was reflected by a 455 dichroic mirror. Emis-
sion from about 500 cells passed through a 455 DC mirror and was split by a 515 dichroic
mirror into two signals. The signals passed through a BP 485/40 filter and a BP 535/30
filter for cyan and yellow, respectively. Data aquisition was performed using a H7421-40
photomultiplier (Hamamatsu) for each channel. Photons per second were counted using
a PCI-6034E board (National Instruments), the photomultiplier were controlled using a
custom-written routine for LabView 7.1 (National Instruments). After establishment of a
stable YFP/CFP ratio (base line), the reservoirs with solutions of stimuli or with phos-
phate buffer were added and removed. and the change in YFP/CFP ratio was monitored
for about 100 sec. FRET was calculated from changes of YFP/CFP ratio by Equation 2.6.
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Figure 2.2: Microscopy setup for in vivo FRET applications. (a) Setup for acceptor photo-
bleaching FRET measurements. Insets: Resulting curves from a typical experiment rep-
resenting change in CFP signal for interacting proteins (upper panel) and no change for
non-interacting proteins (lower panel). (b) Setup for stimulus dependent FRET measure-
ments. Numbers describe used filters with wavelength/bandwith. Details are described in
the main text.
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2.13 Data analysis
All experiments were performed at least in two biological replicates (independent samples
from different days). The resulting values x were calculated to derive an arithmetic mean
x using
x =
1
n
n∑
i=1
xi (2.1)
The deviation between different measurements was determined calculating the standard
error sx using
sx =
s√
n
(2.2)
with s being the standard deviation defined as
s :=
√
s2 (2.3)
Analysis of acceptor photobleaching and stimulus dependent FRET experiments is dis-
cussed in detail in the article from Sourjik and colleagues [194]. Based on that we define
the FRET efficiency EFRET measured in acceptor photobleaching measurements
EFRET =
∆C
C0
(2.4)
as the fractional change in CFP fluorescence. ∆C describes the change in fluorescence due
to the energy transfer to the acceptor, C0 the CFP fluorescence without FRET.
To describe stimulus dependent FRET measurements, the steady state ratio between
the two fluorophores is given as
∆R =
Y FP
CFP
(2.5)
Dependence on stimulus concentration (dose response curve) is calculated using
∆R = RB −R0 −∆RS (2.6)
with RB and RA being the fluorescence ratio without and with stimulus, respectively. ∆RS
represents the difference between the ratios.
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The resulting values are fitted using a Hill equation
FRET ([L]) = m1 ·
(
mm20
mm20 +m
m2
3
)
(2.7)
with m0 as stimulus concentration, m1 as FRET amplitude, m2 being the Hill coefficient
and m3 being K1/2, the stimulus concentration at the half maximum response. To fit the
measurements in Figure 3.9b, m1 to m3 were set 1.
2.14 Software
The following software tools were used during this study:
Axiovision (Version 4.7) Zeiss, Jena
CodonCode Aligner (Version 3.0.3) CodonCode Corporation, USA
Cytoscape (Version 2.8.2) [REF Smoot 2011]
DNA Strider (Version 1.3) Commisariat a l´Energie Atomique, FRA
EnzymeX (Version 3) Mekentosj B.V., NED
Excel 2008 for Mac (Version 12.2.3) Microsoft Corporation, USA
Illustrator (Version CS 3) Adobe Systems, USA
ImageJ (Version 1.38f) W. Rasband, National Institute of Health, USA
http://rsb.info.nih.gov/ij/index.html
KaleidaGraph (Version 4.03) Synergy Software, USA
LabView (Version 7.1) National Instruments, USA
LYX (Version 2.0.1) GU General public license
http://www.lyx.org
Papers (Version 1.9) Mekentosj B.V., NED
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3.1 Fluorescent reporter protein test
To characterize protein-protein interactions in vivo, we used a FRET based microscopy
setup. To investigate proteins using this method, they have to be fused to fluorescent
proteins of two different colours, which have an overlap in their emission and excitation
spectrum, respectively (see chapter 1.5 for details). So far, the commonly used pair was
YFP and CFP [196]. As improved FPs were developed during the last years, we tested
some different pairs in the yellow/cyan and red/yellow range for better FRET properties.
The used setup is similar to the one described in Sourjik et al. from 2002, with donor and
acceptor fusions made to the chemotaxis proteins CheY and CheZ, respectively.
a    b
Figure 3.1: Comparison of fluorescent protein pairs for FRET applications. (a) FACS measure-
ments showing fluorescence intensity dependent on protein expression for yellow CheY-
fluorophore fusions. Error bars represent standard errors. (b) Stimulus dependent FRET
measurements for different FRET-pair combinations (yellow/cyan and red/yellow) fused
to CheY and CheZ, respectively. Upon stimulation of the FRET strain using 300 µM of
chemoattractant serine, the FRET ratio decreases due to changes in CheY/CheZ interac-
tions. Experiments were performed using fusions expressed from plasmids in strain LL5 at
induction levels of 50 µM IPTG and 0.1 % arabinose.
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These two proteins provide a readout of receptor activity and can be stimulated using
chemoattractants. After addition of the chemoattractant serine, the number of CheYZ
complexes decreases and leads to a decrease in FRET ratio. We tested the two yel-
low/cyan pairs Venus/Cerulean [186, 187] and YPet/CyPet [189], with the latter one
optimized for applications in microbial systems. Additionally, the red and yellow pair
YFP/mCherry [188] was investigated, with YFP being the donor molecule. Figure 3.1a
shows the brightness-comparison of yellow fluorescent proteins at different expression lev-
els. The YFP fusion exhibits the highest fluorescence over the whole expression range,
while CheY-Venus is less strong in fluorescence (about 50 % of the YFP signal) for all
tested expression levels. YPet shows a different behaviour with low fluorescence similar to
Venus at lower and strong fluorescence nearly equal to YFP at higher expressions levels.
Notably, this behaviour seems to be in contradiction to the results reporting Venus to be
as bright as YFP and YPet being 60 % brighter than YFP [183].
Figure 3.1b shows the different FRET pairs in the stimulus dependent FRET setup,
either as cognate or non-cognate pairs. Results are summarized in Table 3.1.
Table 3.1: Comparison FRET pairs for FRET-ratio change.
FRET pair change in FRET-ratioupon stimulation
YFP/CFP 20 %
Venus/Cerulean 12 %
YPet/Cerulean 12 %
mCherry/YFP 5 %
YPet/CyPet 2 %
YFP/CyPet ∼1 %
Venus/CyPet ∼1 %
The pair YFP/CFP shows the highest change in FRET ratio of about 20 %. All other
combinations tested displayed a change in ratio below 12 %. Among all tested combina-
tions, the pair YPet/CyPet was documented to be optimized for FRET applications [189].
In our setup, this seems not to be the case.
As the FRET pair YFP/CFP worked best in the in vivo FRET setup, the plasmid based
fusion library of all two-component proteins was constructed using these two fluorophores.
60
3.2 Plasmid library
3.2 Plasmid library
To co-express two proteins independently in E. coli cells, we constructed a comprehensive
vector based library of kinases and response regulators fused to the fluorescent proteins
YFP and CFP. The tag was placed at the C-terminus of the proteins, connected with
a linker containing five amino acids (GSGGG) allowing free rotation and folding of the
fluorophore. For the sensor kinases, this position was chosen as the N-terminal location of
the fluorophore would hinder the proper insertion into the cytoplasmic membrane. For the
response reglators, the position of the tag is not that crucial, as they are relatively small
cytoplasmic proteins.
arabinose
promotor
HK/RR-CFP
fusion
eCFP
chloramphenicol
resistance gene
pACYC
ORI
pBAD33
derivatives
pTrc
promotor
HK/RR-YFP
fusion
eYFP
ampicillin resistance gene
pBR322
ORI
pTrc99a
derivatives
a               b
Figure 3.2: Vector maps of the constructed expression plasmid library. (a) Map of pTrc deriva-
tives for expression of protein-YFP fusions under control of an IPTG inducible promotor.
(b) Map of pBAD33 derivatives for expression of protein-CFP fusions under control of an
arabinose inducible promotor. Arc segments are not scaled to gene length. ORI: origin of
replication. Maps were generated using PlasMapper [208].
All constructed plasmids are derivatives of the two expression vectors pTrc99a and
pBAD33 [209, 200], and a schematic representation of the resulting constructs is shown in
Figure 3.2. pTrc derivates harbour an IPTG inducible pTrc promotor and a pBR322 origin
of replication (ORI). For selection purposes the plasmids includes an ampecillin resistance
marker. To simultaneously express a second protein, we constructed pBAD33 derivates
harbouring a compatible pACYC184 ORI and an arabinose inducible pBAD promotor.
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The selection marker for these vectors is chloramphenicol. The combination of both vec-
tors allow independent expression and tight regulation of two different proteins in the same
cell.
Out of the 28 histidine kinases present in E. coli, we made YFP and CFP fusions to 27
of them under control of a pTrc promotor. Only kdpD-cfp was not constructed as cloning
failed in several attempts. With the exception of evgS, kdpD, lytS and rcsC, where again
several attempts of molecular cloning were not successful, we constructed 24 kinase-cfp
fusions under control of a pBAD promotor. For the response regulators we focused on
fusions to YFP on pTrc plasmids, as for the kinases compatible plasmids encoding CFP
fusions are available. Out of the 30 response regulators we made 26 protein fusions, only
atoC, hydG, lytR and yfhA have not been included due to cloning problems. We left out
the non-canonical two-component proteins CheA and CheY from our library, as they have
not been included in our studies.
3.3 Protein expression levels and stability
The protein-YFP fusions were tested upon the amount of protein degradation inside the
cells using SDS-PAGE and immunoblotting with an anti-GFP antibody. Fusions were ex-
pressed in wildtype MG1655 cells from plasmids under the same conditions used in the
FRET setups. Figure 3.3 shows the immunoblots for the sensor kinase and response reg-
ulator YFP-fusions. The intensities of protein bands were quantified using the software
ImageJ as described in chapter 2.8 to determine the amount of protein degradation com-
pared to the total protein expression. The results are shown in Table 3.2.
The majority of sensor fusions were expressed as full length proteins with a stability
between 46 and 100 % of total protein. The three fusions ArcB, NtrB and RstB showed
a degradation rate of more than 60 %. ArcB-YFP exhibited a major degradation product
with a molecular weight of approximately 40 kDa, NtrB-YFP was degraded in multiple
fragments between 100 and 25 kDa. RstB-YFP only shows the 26 kDa band corresponding
to free YFP. This can be explained by a clip-off of the fluorophore. Subsequently these
three fusions were not used in further experiments. Fluorescent protein fusions to the
response regulator proteins exhibited a stability of at least 67 % of full length protein for
all tested reporters, enabling their usage in the subsequent in vivo studies.
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Figure 3.3: Immunoblots depicting histidine kinase (a) and response regulator (b) degradation.
Kinase-YFP fusions were tested for the amount of protein degradation using an anti-GFP
antibody. eYFP lanes were added as control. Fusions were expressed from plasmids in
MG1655 wildtype cells. Numbers represent the size of molecular weight marker bands in
kDa. Fusions exhibiting large amount of degradation are labelled by an asterisk.
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Table 3.2: Fractional degradation of kinase- and regulator-YFP fusions. Numbers represent
percentage of protein degradation for fusions expressed in MG1655 wildtype cells. Fusions
exhibiting a degradation rate ≥ 60 % are displayed in bold.
Kinases Regulators
Fusion Amount of Fusion Amount of Fusion Amount of Fusion Amount ofdegradation degradation degradation degradation
ArcB 0.96 NarQ 0.27 ArcA 0.02 NarP 0.14
AtoS 0.08 NarX 0.25 BaeR 0.03 NtrC 0.12
BaeS 0.20 NtrB 0.66 BasR 0.07 OmpR 0.11
BarA 0.20 PhoQ 0.28 CitB 0.11 PhoB 0.21
BasS 0.10 PhoR 0.32 CpxR 0.07 PhoP 0.19
CitA 0.02 QseC 0.28 CreB 0.43 QseB 0.24
CpxA 0.11 RcsC 0.44 CusR 0.13 RcsB 0.16
CreC 0.02 RstB 1.00 DcuR 0.10 RstA 0.07
CusS 0.00 TorS 0.00 EvgA 0.42 TorR 0.10
DcuS 0.15 UhpB 0.00 FimZ 0.12 UhpA 0.11
EnvZ 0.30 YedV 0.54 KdpE 0.21 UvrY 0.36
EvgS 0.46 YehU 0.00 NarL 0.02 YedW 0.23
HydH 0.20 YfhK 0.00
KdpD 0.43 YpdA 0.45
To determine the copy number of proteins under our experimental conditions, FACS
analyses was performed on the YFP fusions. The resulting copy numbers for the majority
of all E. coli TCS components are shown in Figure 3.4. Protein expression in the FACS
experiments was not induced using IPTG, the protein expression is due to the leakyness
of the pTrc promotor. The measured numbers represent thereby the number of protein
fusions additionally to the native unlabeled proteins. Results showed a large copy number
distribution between the different sensors and regulators, spanning four and five orders
of magnitude, respectively. Between the kinases, KdpD and QseC showed the highest
expression level with approximately 24000 and 22000 copies, respectively. In contrast,
EnvZ and YpdA exhibited the lowest number with 180 and 450 copies per cell, respectively.
In case of the regulators, YedW shows the highest copy number with 154000 proteins/cell,
and the lowest expression was measured for CreB with 315 copies per cell. Our measured
copy numbers display a large distribution compared to the values available in literature,
reporting about 100 copies of sensors and 3000 copies of regulators per cell and assuming
these numbers for all existing systems [91, 93, 94].
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a
b
Figure 3.4: Copy numbers of histidine kinases and response regulators. FACS data showing the
copy numbers of histidine kinase (a) and response regulator (b) YFP-fusions expressed
from pTrc plasmids without induction in MG1655 wildtype cells. Absolute protein numbers
were determined after FACS calibration (see section 2.10 for details).
To deduce the range of overexpression for sensors expressed from our plasmids, represen-
tative protein fusions were inserted into the bacterial chromosome to determine the native
protein expression levels under control of the native promotors. A C-terminal in-frame
insertion of YFP allowed quantification of the expression levels. The determined values
and (for comparison) the correspondent numbers of plasmid expression are shown in Table
3.3.
The derived values for the three kinases BaeS, CitA and CusS display a copy number
between 300 and 600 sensors per cell under the native promotor. Comparing these results
with the plasmid based sensor expression, we estimate an overexpression rate of our fusions
between 3.5 and 13 fold compared to the chromosomal (native) expression levels.
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Table 3.3: Comparison between chromosomal and plasmid based expression. Absolute num-
bers were determined using FACS analysis after calibration (see section 2.10 for details).
Variations represent standard errors.
Copy number
Kinase fusion plasmid chromosome
BaeS 4114 ± 341 320 ± 89
CitA 3777 ± 1171 634 ± 191
CusS 1159 ± 290 334 ± 113
3.4 Sensor and regulator localization
Intracellular localization of sensor kinases was investigated using fluorescence microscopy
imaging. The different sensors were either expressed as YFP- or CFP-fusions (to derive the
lowes possible copy number), and the used conditions and copy numbers are summarized
in Table 3.4. Figure 3.5 shows representive pictures for all HKs which were expressed as
full-length fusions (see Table 3.2 for details).
The sensor´s localization pattern can be classified in three different classes: homogenous
localization around the cell periphery (Figure 3.5a), distinct localization pattern (Figure
3.5b) and intermediate punctuated distribution (Figure 3.5c). To determine possible differ-
ences in protein localization dependent on presence of wildtype proteins or nutrient source
(influence of catabolite repression), localization was additionally tested under different
growth conditions. The results are summarized in Table 3.5. Localization pattern shown
in Figure 3.5a was exhibited by the sensors AtoS, BasS, CreC, DcuS, KdpD, NarX, QseC
and YedV, and it was visible at all tested expression levels and growth conditions. Two
kinases, EvgS and TorS, showed a specific cluster formation predominantly occuring at the
cell poles (Figure 3.5b).The remaining sensors showed a milder tendency to form clusters
and exhibited an intermediate punctuated kinase distribution shown in Figure 3.5c. This
pattern was only visible at lower expression levels, changing into a homogenous localization
with increased protein numbers. Some of the histidine kinases showed in-deed a different
localization dependent on the applied growth conditions, with a higher tendency for clus-
ter formation in rich medium compared to TB or Minimal A (Table 3.5). The presence
of wildtype protein seems not to affect the localization pattern, as there was no difference
visible between results obtained in wildtype or the corresponding kinase knockout.
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Figure 3.5: Cellular localization of histidine kinases. Fluorescence microscopy snapshots showing
intracellular localization of kinase-YFP fusions. (a) Homogenous localization at the cell
periphery. (b) Pattern of distinct protein localization. (c) Intermediate protein localiza-
tion. Proteins were expressed from plasmids in MG1655 wildtype cells. Copy numbers for
the different fusions are shown in Table 3.4. Scale bar: 2 µM.
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Table 3.4: Imaging conditions histidine kinase localization. Copy numbers are measured as de-
scribed in Section 2.10.
His-kinase imaged as induction level copies per cellYFP CFP
AtoS x 0 µM IPTG 3800
BaeS x 0.005% Ara 8200
BarA x 0.01% Ara 1400
BasS x 0 µM IPTG 4100
CitA x 0 µM IPTG 3700
CpxA x 0 µM IPTG 2300
CreC x 7 µM IPTG 2000
CusS x 30 µM IPTG 2000
DcuS x 0.005% Ara 7600
EnvZ x 30 µM IPTG 1800
EvgS x 0 µM IPTG 7100
HydH x 3.5 µM IPTG 2400
KdpD x 0 µM IPTG 24000
NarQ x 0 µM IPTG 11300
NarX x 0 µM IPTG 2700
PhoQ x 0.0001% Ara 21000
PhoR x 9 µM IPTG 2000
QseC x 0.0001% Ara 15800
RcsC x 30 µM IPTG 1800
TorS x 0 µM IPTG 6500
UhpB x 0 µM IPTG 1800
YedV x 0 µM IPTG 12800
YehU x 30 µM IPTG 2300
YfhK x 5 µM IPTG 2000
YpdA x 30 µM IPTG 1000
Additionally, we studied the intracellular localization of the majority of TCS response
regulator proteins. A corresponding fluorescence image is shown in Figure 3.6. All response
regulators exhibit a homogenous distribution in the cytoplasm similar to the on displayed
for ArcA in Figure 3.6. In all cases, there was no specific localization pattern to spots or
protein complexes visible. It should be mentioned that some of the fusions showing high
expression levels (for example bright cells of BaeR or YpdB) exhibit dark spots at the cell
poles. These spots represent most probably vacuoles or aggregates of nutrients or other
substances.
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Figure 3.6: Fluorescence microscopy snapshots showing intracellular localization of regulator-
YFP fusions. Proteins were expressed from plasmids in MG1655 wildtype cells without
induction of protein expression. Scale bar: 2 µM.
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3.5 Kinase-kinase interactions
3.5.1 FRET screen on cognate sensor pairs
To test possible interactions between different two-component pathways on the sensor
level, we performed a screen using an in vivo acceptor photobleaching FRET assay. For
all following kinase-kinase FRET experiments, the copy numbers were adjusted as shown
in Table 3.6. The results from the sensor screen are shown in Figure 3.7.
Figure 3.7: In vivo bleach FRET investigation of kinase homodimers. Protein interactions be-
tween sensor kinases of the same kind measured by acceptor photobleaching FRET. Red
line represents 0.5 % scored as threshold for positive interactions. Fusions were expressed
from plasmids in MG1655 wildtype background with copy numbers of about 2000 per
fusion. Error bars represent standard errors.
Out of the 21 sensor kinases investigated, we could show interactions for 12 of them,
namely AtoS, BaeS, BarA, CitA, CpxA, DcuS, NarQ, PhoQ, QseC, TorS, UhpB and YedV.
All of them showed an increase in FRET ratio after photobleaching of more than 0.5 %
(red line in Figure 3.7), which is scored as threshold for positive protein interactions. The
strongest ratio change was measured for the three kinases BaeS (4.61 %), PhoQ (2.75 %)
and QseC (3.03 %). Those three pairs are among the fusions exhibiting high copy numbers
under our experimental conditions (Table 3.6), which might explain the relatively high
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values of FRET ratio change due to a high probability of interactions inside the cell. The
pairs showing a FRET value below 0.5 % are scored as non-interacting, which results from
no energy transfer between the two fluorophores. The reason for this could be structural
properties of the sensors, which separate the two C-terminal fluorophores to a distance
greater than 10 nm.
Table 3.6: Histidine kinase copy numbers for acceptor photobleaching experiments. Copy num-
bers were determined as described in Section 2.10.
copies per cell
His-kinase YFP fusion CFP fusion
AtoS 3800 9000
BaeS 2800 8200
BarA 3000 1400
BasS 7500 4100
CitA 3000 3700
CpxA 3000 2300
CreC 2500 2000
CusS 1160 2000
DcuS 12000 7600
EnvZ 180 1800
HydH 3400 2400
NarQ 9000 11300
NarX 3000 2700
PhoQ 15000 21000
PhoR 3900 2000
QseC 18000 15800
TorS 6000 6500
UhpB 1700 1800
YedV 10000 12800
YfhK 1700 2000
YpdA 1900 1000
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3.5.2 FRET measurements on kinase cross-talk
To elucidate possible interactions between sensor proteins of different kinds, we repeated
the former screen by pairwise expressing kinase fusions in different combinations. The
results are shown in Figure 3.8.
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Figure 3.8: Acceptor photobleaching screen between HK-YFP and -CFP fusions. Heatmap
represents measured interactions between histidine kinases of different kinds using FRET.
Blue squares represent no interaction (change in FRET ratio < 0.5 %), red squares repre-
sent identified interactions (ratio change ≥ 0.5 %). Fusions were expressed from plasmids
in MG1655 wildtype background. Copy numbers of kinase fusions are shown in Table 3.6.
The red diagonal line shown in the heatmap represents the interactions already shown
in Figure 3.7, added to derive a comprehensive picture. Out of the measured combina-
tions of different sensors, we identified in total 11 positives including two hits observed
in both orientations, namely CpxA/PhoQ and BaeS/DcuS. This results in 9 identified
protein hetero-interactions in total (BaeS/DcuS, BaeS/YedV, BarA/DcuS, BarA/NarQ,
BarA/QseC, CitA/CpxA, CpxA/PhoQ DcuS/NarQ and DcuS/PhoQ), representing 12.5
% cross-talk among the pairs investigated. It should be mentioned that occurence of in-
teractions in one orientation only most probably result from differences in the expression
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levels between the two fusions (see Discussion for details).
3.5.3 Stimulus dependent FRET on cognate pairs
To derive informations about the dynamic range and sensitivity of kinase interactions, we
performed stimulus dependent FRET measurements on different kinase-kinase pairs. The
main focus was on the interacting candidates identified in Figure 3.8. An overview over
the tested combinations is shown in Table 3.7.
Table 3.7: Kinase-pairs tested in stimulus dependent FRET measurements. +: combination
responded to applied stimulus; -: combination did not respond.
cognate pairs
Kinase 1 Kinase 2 Stimulus Response
BaeS BaeS CuSO4 +
CitA CitA citrate +
CpxA CpxA citrate, MgSO4 -
CusS CusS CuSO4 -
EnvZ EnvZ sucrose, KCl, NaCl -
HydH HydH ZnSO4, PbCl2 -
NarX NarX NaNO2, NaNO3 -
PhoQ PhoQ MgSO4, phosphate -
TorS TorS TMANO -
non-cognate pairs
Kinase 1 Kinase 2 Stimulus Response
CitA CpxA citrate +
CpxA PhoQ MgSO4 +
BaeS DcuS fumarate, CuSO4 -
BaeS YedV ZnSO4 -
BarA NarQ NaNO2, NaNO3 -
DcuS PhoQ fumarate, MgSO4 -
DcuS NarQ fumarate, NaNO2, NaNO3 -
DcuS BarA fumarate -
Out of the 9 cognate kinase pairs tested, only BaeS and CitA showed change in FRET
in reponse to their cognate stimulus. The other tested pairs did not exhibit any response
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to the applied stimuli, which might be due to no occuring change in sensor confirmation
upon stimulation (see discussion for details) or the ineffectiveness of the used substance.
For the sensor BaeS, we were able to measure a stimulation dependent FRET response
using CuSO4 (Figure 3.9a).
  a                  b
Figure 3.9: Stimulation-induced conformational change for BaeS. (a) FRET curve for BaeS-
YFP/BaeS-CFP showing the change in YFP/CFP-ratio upon stimulation with CuSO4.
Arrows represent addition (↑) and removal (↓) of the stimulus; concentrations are indi-
cated. (b) Dose-response curve for BaeS dimer calculated from measurements as shown
in (a). Error bars represent standard errors. Values were fitted using a Hill equation (see
Equation 2.7 for details).
Figure 3.9 shows the increasing change in YFP/CFP-ratio upon stimulation with increas-
ing concentrations of CuSO4, the substance sensed by the BaeSR system. The changes in
ratio reflect a conformational change within a sensor dimer or between different sensors
in a complex induced by the stimulus. The sensitivity of the FRET setup allows us to
measure concentrations between 50 nM and 30 µM, whereas the ratio change saturates
around a concentration of 10 µM CuSO4. Figure 3.9b shows a dose response curve de-
rived from FRET measurements as shown in panel a. The curve was fitted using Equation
2.7. Another described stimulus for the BaeSR system is indole, but application of this
substance on the sensor pair did not show any change in the FRET-ratio.
With CitA, we identified another sensor responding in our stimulus dependent FRET
setup upon application of the cognate chemical signal (Figure 3.10). CitA exhibits very
weak changes in FRET ratio upon stimulation using citrate. Nevertheless, this seems to
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be specific as the FRET ratio decreases upon stimulation, in contrast to an increase in
ratio for unspecific interactions.
Figure 3.10: Stimulation dependence of FRET for CitA. Blue and orange curves show single fluo-
rescence channels, black curve shows YFP/CFP-ratio change of CitA dimers as response
to citrate. Arrows represent addition (↑) and removal (↓) of the stimulus. Citrate con-
centrations of 1 and 10 mM were used, applied without changing back to buffer.
3.5.4 Stimulus dependent FRET on kinase cross-talk
Given the possibility to use stimulus dependent FRET measurements to measure kinase-
kinase interactions, we expanded our experiments on non-cognate pairs identified before
(see Table 3.7 for details). Out of the 8 tested hetero-interactions we were able to measure
stimulus dependence for CitA/CpxA and CpxA/PhoQ (Figure 3.11). Figure 3.11a shows
the change in YFP/CFP-ratio for the non-cognate sensor pair CitA and CpxA. The applied
stimulus is 10 mM Citrate, the substance detected by CitA. Figure 3.11b displays a FRET
measurement for the sensor pair CpxA and PhoQ. We applied MgSO4 in concentration
between 30 µM and 100 mM sensed by PhoQ. The heteropair showed a specific response to
the different concentrations of MgSO4. For the kinase CpxA, only the unspecific stimulus
pH is known. As pH changes intensities of YFP and CFP fluorescence, this was not applied
in the FRET measurements.
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  a                  b
Figure 3.11: Histidine kinase cross-talk. (a) Stimulus dependent FRET between CitA and CpxA
kinases. (b) FRET between CpxA and PhoQ kinases. Curves showing YFP/CFP-ratio
change of dimers as response to a stimulus. Arrows represent addition (↑) and removal
(↓) of the stimulus. Stimuli and concentrations are indicated.
77
3 Results
3.6 Kinase-regulator interactions
3.6.1 Acceptor photobleaching FRET
To confirm interactions between sensor kinases and their cognate regulators we performed
acceptor photobleaching FRET measurements on different HK-RR pairs. Additionally,
we wanted to identify pairs we could assay with our stimulus-dependent FRET setup for
further kinetic measurements. The identified pairs are listed in Table 3.8.
Table 3.8: Kinase-regulator bleach FRET. FRET efficiencies were determined using acceptor pho-
tobleaching. Majority of the pairs were tested in both orientations (HK-YFP/RR-CFP and
HK-CFP/RR-YFP). -: no change on FRET efficiency; n.d.: not determined.
Sensor Regulator FRET efficiency
HK-YFP/RR-CFP HK-CFP/RR-YFP
BaeS BaeR 0.92 % n.d.
BasS BasR 1.08 % 1.30 %
CpxA CpxR n.d. 1.81 %
CreC CreB n.d. -
CusS CusR n.d. 1.95 %
EnvZ OmpR 0.49 % 2.33 %
PhoQ PhoP 1.46 % -
QseC QseB 2.56 % 4.76 %
RstB RstA n.d. -
YedV YedW 2.01 % 9.35 %
Additionally we tested a set of non-cognate kinase-regulator pairs in the acceptor pho-
tobleaching setup to screen for possible interactions. Starting point were the identified
interactions from the in vitro study performed by Yamamoto and colleagues [136] and
computational predictions from the van Nimwegen group in Basel (Erik van Nimwegen,
personal communication and [127]). The tested interaction set is shown in Table 3.9. All
except one pair (YedV/CusR) are tested in the orientation HK-CFP/RR-YFP. This due to
the leaky expression of the pTrc controlled YFP fusions. As regulators are more abundant
than sensors, we assumed this orientation not to have any negative effects due to expression
ratios (see Discussion for details).
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Table 3.9: FRET test on cross-talk HK-RR pairs identified in vitro and predicted. Combinations
are based on in vitro experiments [136] and computational predictions (Erik van Nimwegen,
personal communication and [127]). Confirmed interactions using acceptor photobleaching
FRET are shown in bold. All pairs, except were noted, are tested in the orientation HK-
CFP/RR-YFP.
Sensor Regulator FRET efficiency Sensor Regulator FRET efficiency
in vitro data computational predictions
BaeS CheY -1 AtoS CusR 0.51 %
BaeS RssB - BaeS CpxR -1
BarA CusR - BasS QseB 0.79 %
BarA NarL - BasS PhoP -1
BarA NarP - CpxA OmpR -1
CreC PhoB - CreC BasR -1
CusS PhoB - CusS YedW 2.23 %
DcuS CheY -1 EnvZ RstA -
DcuS CitB -1 EnvZ CpxR -1
DcuS PhoB - PhoQ NtrC -1
DcuS RssB - QseC CreB -
EnvZ CpxR -1 RstB OmpR -1
EnvZ PhoP - YedV CusR 0.64 %2
HydH RssB -
NtrB CitB -1
NtrB RssB -
PhoR CpxR -
RstB CpxR -
UhpB CitB 6.61 %
UhpB CusR -
UhpB KdpE 0.89 %
UhpB NarL -
UhpB NarP -
UhpB NtrC -
YedV CusR -
-: no change in FRET efficiency
n.d.: not determined
1: confirmed in both orientations
2:measured in orientation HK-YFP/RR-CFP
Within the set of in vitro data we were able to identify positive interactions between the
Kinase UhpB and the regulators KdpE (0.89 % change in FRET ratio) and CitB (6.61 %
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change in FRET ratio), which are both significant. For the tested candidates from com-
putational predictions, we measured a change in the FRET for the pairs AtoS/CusR (0.51
%), BasS/QseB (0.79 %), CusS/YedW (2.23 %) and YedV/CusR (0.64 %). Nevertheless,
the vast majority of computational predictions or in vitro data did not show any cross-talk
between the different proteins. The possible reasons for this might be the differences with
the experimental setups used for the in vitro data (see discussion for details) and that
predictions might not reflect the in vivo situation.
3.6.2 Stimulus dependent FRET
Focusing on those pairs where we identified an interaction in the acceptor photobleaching
setup (see Table 3.8), we tested their responses using their cognate stimulus. The results
are summarized in Table 3.10.
Table 3.10: Kinase-regulator FRET upon stimulation. Pairs were tested using kinase-CFP and
regulator-YFP fusions. Copy numbers were adjusted to about 2000 sensor and 5000
regulator copies per cell, if possible. Fusions were expressed in wildtype MG1655 cells.
Sensor Regulator FRET response upon stimulation
HK-CFP/RR-YFP
BaeS BaeR +
BasS BasR -
CusS CusR -
CpxA CpxR n.a.
DcuS DcuR -
EnvZ OmpR -
NarX NarL -
PhoQ PhoP -
QseC QseB -
RstB RstA -
TorS TorR -
UhpB UhpA -
YedV YedW n.a.
+: response upon stimulus; -: no response
n.a.: no stimulus known
Among the different TCS tested the majority did not show a response upon the certain
stimulus. This is probably because of the orientation of the kinase and regulator fusions
against each other, which separate YFP and CFP to a distance to far for FRET. Only for
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one system (BaeS and BaeR) we where are able to measure stimulus dependent kinetics
between sensor and regulator. Figure 3.12 shows the BaeS kinase and BaeR regulator,
stimulated with 2 mM of the described stimulus indole.
Figure 3.12: Stimulus dependent FRET between BaeS and BaeR. Curves showing sensor-
regulator response to indole. Blue curve represents the YFP/CFP-ratio. Arrows represent
addition (↑) and removal (↓) of the stimulus, concentrations are indicated.
The system shows a change in YFP/CFP-ratio, indicating a change in inter-protein
interaction kinetics upon stimulation. The two proteins showed no response to stimulation
using varying concentrations of CuSO4, another stimulus of the system. This finding seems
to be in contradiction to the results obtained for the BaeS sensor alone (see Figure 3.9),
and the reason might be a different conformational mechanism for the sensing of indole
and CuSO4 (see discussion for details).
3.7 Promotor activation
3.7.1 Kinase overexpression screen
To test for possible influences of sensors on the downstream promotor activity, we ex-
pressed kinases without any stimulus in presence of promotor-GFP fusion plasmids [185].
These reporter plasmids harbour a gene coding for a fast folding GFP-variant under control
of different E. coli promotors, and allows the measurement of changed GFP-fluorescence
as readout of changed promotor activity. We focused on a subset of systems, where we
identified interactions on the sensor level before (Figure 3.8). All kinases were induced
with 10 µM IPTG in wildtype cells to achieve overexpression and strenghten their possible
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effects. Dependent on the kinases there are three possible outcomes expected: no change
in promotor activity, increased or decreased activity upon sensor expression. The results
Figure 3.13: Promotor activation upon histidine kinase overexpression. Change in promotor
activity upon overexpression of sensor kinase fusions. The first bar of each promotor
represents the cognate kinase-promotor pair. All kinases were induced using 10 µM
IPTG and expressed in wildtype MG1655 cells. Numbers are derived from promotor-
GFP fusions measured by FACS. Values were normalized to the promotor activity in
the absence of kinase-fusions. Error bars represent standard errors, asterisks indicate
combinations with slower cell growth.
are shown in Figure 3.13. For the majority of the tested promotor fusions we were not
able to see a strong effect upon kinase overexpression. This is possibly because sensor
overexpression has no effect on the intrinsic kinase and/or phosphatase activity, which is
changed by a cognate stimulus, only. Therefore, kinase overexpression is not leading to
a difference in the regulator´s phosphorylation state, which would change the amount of
regulators bound to promotors. Subsequently, there is no impact on the promotor activity
detectable. Significant upregulation was seen for the four promotors cusC through YedV,
glnA through NtrB, uhpT through NarQ and wza through ArcB. Significant downregula-
tion was seen for the cognate pair dcuB and DcuS. Interestingly, all other of the cognate
kinase-promotor pairs did not show any substantial effect on protein overexpression, which
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might be due to the same lack of effects mentioned before.
3.7.2 Complementation of sensor-YFP fusions
To check the functionality of kinase-YFP fusions we performed complementation experi-
ments. As in most of the cases sensor deletion exhibits no clear phenotype, we chose an
assay providing a readout of promotor activity. We focused our experiments on the candi-
date systems identified in the kinase FRET screen (Figure 3.8). Where available (and the
downstream promotor is known), we used GFP fusions from the E. coli promotor collec-
tion [185] and tested the change in promotor activity. Using FACS analysis we measured
activity in the wildtype, the kinase knockout and the strain complemented with the cor-
responding kinase-fusion. Results for all tested promotors are summarized in Table 3.11
and positives are shown in Figure 3.14.
Table 3.11: Promotor activity change upon kinase deletion and complementation. Values are
derived from promotor-GFP fusions using flow cytometry. Corresponding promotors are
shown in brackets.
Kinase (Promotorfusion) Complementation
CitA (citT ) n.e.
CpxA (htrA) -
DcuS (dcuB) +
EnvZ (ompC ) +
EnvZ (pstS ) n.e.
NarX (fdnG) -
NarX (frdA) n.e.
PhoQ (phoA) -
PhoR (phoA) +
QseC (flhD) +
QseC (fliA) +
QseC (fliC ) +
QseC (motA) n.e.
RcsC (rcsA) n.e.
RcsC (wza) n.e.
UhpB (uhpT ) -
+ - complementation; - - no complementation
n.e. - no effect of the knockout visible
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In case of the four promotors fdnG (NarX), htrA (CpxA), phoA (PhoQ) and uhpT
(UhpB), complemetation did not work as there is no effect on the promotor activity visible.
For a group of promotors we do not even see a effect of the corresponding kinase knockout.
Those include citT (CitA), frdA (NarX), motA (QseC), pstS (EnvZ) rcsA and wza (both
RcsC).
Figure 3.14: FACS based complementation assay. Change in promotor activity upon deletion (ko)
and complementation (ko/sensor fusion) with sensor kinase fusions. Letters below lines
represent promotor fusion. Values are derived from promotor-GFP fusions using FACS.
Values were normalized to the wildtype (wt) promotor activity. Error bars represent
standard errors.
YFP-fusions of the four sensors DcuS, EnvZ, PhoR and QseC are able to restore the
promotor activity, at least partially. In these cases the obtained results indicate the (par-
tial) functionality of the constructed protein fusions. For flhD (QseC) and phoA (PhoR)
deletion of the sensor leads to an increase in promotor activity, which drops again upon
addition of the cognate sensor. dcuB (DcuS), fliA, fliC (both QseC) and ompC (EnvZ)
show an activity decrease in absence of the kinase, which (partially) increases again upon
complementation with the kinase fusion.
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3.7.3 Cross-activation of sensors on promotors
For those kinases performing cross-interaction in the acceptor photobleaching FRET assay
(Figure 3.8), we were interested whether they also perform cross-talk on the promotor
level. The detailed FACS results for the kinases that show a specific effect on non-cognate
promotor activity is shown in Figure 3.15.
Figure 3.15: Cross-talk effects on promotor level. Change in promotor activity upon deletion (ko)
of cognate and non-cognate sensor kinase fusions and complementation (HK) using the
specific fusion protein. Values are derived from promotor-GFP fusions using FACS. Values
were normalized to the wt promotor activity. Error bars represent standard errors.
The FACS results display an effect on the non-cognate promotors for the sensor pairs
DcuS/NarQ (in both directions), DcuS/PhoQ, DcuS/BarA and CitA/CpxA. In all cases
the promotor activity changes for if the proposed cross-talking kinase is knocked out.
Additionally, complementation with this kinase fusion restores the promotor activity at
least partially. This result confirms the physiological relevance of the kinase interactions
we found in the FRET screen before.
3.7.4 Stimulus dependence of promotor activity
Table 3.12 shows a summary of stimuli for different two-component systems in E. coli.
The listed substances have been reported in different experimental studies performed on
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the different systems (for references see Table 3.12).The reported stimuli summarized in
Table 3.12 were used to test their effect on promotors known to be downstream targets of
two-component systems.
Table 3.12: Stimuli of histidine kinases reported in literature.
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Promotors were therefore identified using the EcoCyc database (http://EcoCyc.org/,
[221]). Figure 3.16 shows the results of the performed FACS promotor activity screen.
Figure 3.16: FACS promotor stimulation screen. Bars show the rate of change in promotor activity
upon stimulation compared to the unstimulated state. Values were derived by FACS using
GFP promotor reporter plasmids. Names of promotors, used stimuli and their concen-
trations are indicated inside the bars. Names below the x-axis indicate the corresponding
sensor kinase(s). Error bars represent standard errors.
Among all tested reporter fusions we identified a couple of promotors which we could
stimulate using the reported substance. The uhpT promotor (stimulated through UhpB
with 0.04 µM glucose-6-phosphate) exhibits the highest change in activity with a 100 fold
activation. Four promotors show a significant activation with an at least 2 fold increase
in activity: cusC (through CusS, 100 µM CuSO4), ompC (EnvZ, 500 mM NaCl) ytfE
(NarQX, 100 mM NaNO2) and zraP (HydH, 1 mM ZnSO4). Six promotors exhibited a
significant decrease in activity upon stimulation with a chemical cue, leading to a residual
activity of about 50 %: citC (CitA, 10 mM Citrate), fdnG (NarQX, 100 mM NaNO3 and
2 mM Fumarate), glnA (NtrB, 0.03 µM α-ketoglutarate), nrfA (NarQX, 100 mM NaNO2),
phoA (PhoQR, 2 mM Fumarate) and ygjJ (BasS, 500 µM FeSO4). Compared to the
results from complementation experiments (Figure 3.14), only fdnG and phoA showed a
response to their stimulus. The other the complementing promotors did not show any
change in gene expression upon stimulation. For all identified cases, these results provide
us a downstream readout for a number of two-component pathways, allowing their further
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characterization in for example stimulus dependent FRET experiments. Nevertheless, the
majority of tested promotors did not show a significant response upon stimulation. The
reason might be the application time of the stimulus, which was added to the liquid culture
for 30-45 minutes. For some processes this might be too short to elicit a response. Another
explanation could be that the documented stimuli have no effect on the two-component
systems as reported before. In some cases, negative results might be due to the growth
conditions, as we used minimal A medium and aerobic conditions for all samples. This
might have a negative effect on the gene expression of some TCS proteins.
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Prokaryotes occupy all possible habitats in earths biosphere and developed several different
ways of signal perception and transmission. Successful information processing allows for
adaptation, maintenance of their viability, and the movement towards more favourable con-
ditions. Two-component systems are the most widespread signaling pathways in prokary-
otes and can be found in nearly all bacteria and archaea. The relatively simple layout of
these systems and the modularity in their architecture makes them suitable to study basic
principles of signal transduction. There is a high degree of homology between different
systems and even organisms. A detailed understanding of the mechanisms of E. coli´s
two-component systems will lead to a system-wide view of the cells signaling and infor-
mation processing properties. Furthermore, given the high degree of homology between
systems of different organisms, such analysis will shed light on signaling performed in other
prokaryotes. This knowledge can be used to better understand processes involved in vir-
ulence or pathogenicity and to construct novel signaling circuits and genetic networks in
synthetic biology or metabolic engineering.
4.1 Fluorescent protein reporter fusions
4.1.1 Test of fluorescent proteins
Before we started to construct a library of fluorescently labelled proteins for our exper-
iments, we performed a set of preliminary tests on different fluorophores. As there has
been much optimization on fluorescence proteins being performed during the last years,
the aim was to identify a combination of two fluorophores that works best in imaging,
flow cytometry and our in vivo FRET applications. As comparison to the well known
FRET-pair eYFP and eCFP, we tested additionally YPet and Venus as yellow, CyPet and
Cerulean as cyan and mCherry as red fluorophore, respectively. Criteria to be fulfilled
for the chosen proteins were the following: (i) improved brightness or photostability com-
pared to the established ones, (ii) no tendency to form dimers between two fluorophores
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(iii) combinations with emission- and excitation-spectra allowing FRET and (iv) spectral
properties fitting to the filter sets in the existing fluorescence microscopes.
For the yellow fluorescent proteins we performed flow cytometry measurements over
a wide range of expression levels (Figure 3.1a). The goal of these experiments was to
determine the brightness of different yellow fusions and to identify the protein best suited
for imaging and flow cytometry applications. The best performance was exhibited by
YFP, which showed the highest signals for all expression levels. The optimized proteins
Venus and YPet displayed lower and similar fluorescence intensities compared to YFP,
respectively. This contradicts the results reporting a brightness of Venus nearly identical
to the one of YFP, and YPet being around 60 % brighter than YFP [183]. In this review
the brightness has been calculated as product between the molar extinction coefficient
and the quantum yield determined for the different proteins. In a comparison of relative
whole cell fluorescence of YFP, Venus and YPet [189], YFP displays 76 % and YPet 49
% of Venus´ fluorescence. This difference might be due to a low expression level of the
improved fluorophores under our conditions, which leads to a decreased fluorescence to
background ratio. Taken together, YFP showed stronger (or similar at higher expression
levels) brightness in our hands compared to YPet and Venus, respectively.
To identify the best combination for our in vivo FRET applications, we compared donor
fusions made to CheY and acceptor fusions made to CheZ, respectively (Figure 3.1b and Ta-
ble 3.1). The pairs were tested for their energy transfer efficiency, represented by a decrease
in the FRET ratio upon stimulation of the chemotaxis pathway using the chemoattractant
serine [196]. This decrease is due to a change in the interaction between CheY and CheZ,
and provides a direct and quantitave readout of the pathway activity. As reference we
measured the FRET change between CheY-YFP and CheZ-CFP, which was about 20 %
between unstimulated and stimulated cells. All other tested combinations showed a change
in ratio about or below 12 %. Nguyen and co-workers described their pair YPet/CyPet
to be especially optimized for in vivo FRET applications in a bacterial expression system
[189], a fact which we could not confirm in our setup. The reason for this difference re-
mains unclear. One explanation might be the low expression level of our fusions under the
used conditions as dicussed above. Additionally, the ratio between the donor and acceptor
fluorophores might not be optimal, which results in a low FRET efficiency. In case of
the non-cognate conbinations, additionally the fluorophore properties might not match to
ensure an efficient energy transfer between protein.
Taken together, our preliminary experiments using flow cytometry and FRET identified
YFP and CFP as the best candidates to be used in our setups. Therefore we made all
protein fusions for the plasmid library using these two fluorophores.
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4.1.2 Plasmid library of fluorescent labelled proteins
We constructed a comprehensive library of plasmids encoding histidine kinases and re-
sponse regulators fused to either YFP or CFP, respectively. Out of the 28 histidine kinases
present in E. coli, we made YFP and CFP fusions to 27 of them under control of a pTrc
promotor and 24 kinase-cfp fusions under control of a pBAD promotor. The other kinases
were not included as cloning failed in several attempts. For the 30 response regulators
we made 26 protein fusions, the residual regulators have not been included due to cloning
problems. We left out CheA and CheY from our library, because they are part of a non-
canonical two-component system.
We tested the protein fusions for their full-length expression and the amount of protein
degradation using SDS-PAGE and immunoblotting with an anti-GFP antibody (Figure 3.3
and Table 3.2). The majority of kinase fusions displayed protein degradation below 60 %;
only three were excluded from further investigations because of extensive protein degration.
A change in the linker sequence could probably solve the degradation problem in future
experiments. The response regulator fusions were tested in a similar fashion (Table 3.2),
all of them showed degradation below 33 %. This means that there was no limitation in
using the regulator fusions in further experiments. Generally, the sensor kinases showed
a higher amount of protein degradation in contrast to the response regulators. This was
expected, given that for membrane proteins there is a much higher probability to interfere
with proper folding by adding a fluorophore.
So far, only little is known about the copy numbers of two-component proteins in bac-
teria. There have been a few studies showing that kinases are in relative low abundance
compared to regulators, with ratios between 1:30 or 1:50 [93, 95]. The total numbers have
been estimated to 100 and 1000 copies for the sensors EnvZ and KdpD, respectively, and
around 3500 for the regulators OmpR and KdpE [91, 93]. It has been suggested that the
copy numbers derived for EnvZ and OmpR are representative for other two-component
systems [94]. We constructed three chromosomal kinase-YFP fusions (to baeS, citA and
cusS ) to be able to estimate their native expression level. Under our conditions, the fu-
sions exhibited copy numbers between 300 and 600 molecules per cell. This leads us to
the conclusion that a number of 100 kinase copies per cell might be an underestimation,
and this is further confirmed by the results derived from the plasmid based measurements
discussed below.
To estimate the expression level of the plasmid based HK- and RR-fusions, we performed
flow cytometry measurements using the YFP fusions. The motivation behind these exper-
iments was to derive reliable copy numbers which allowed us to adjust the protein ratio in
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our FRET experiments, especially for the sensor heterodimer experiments (Figure 3.8) and
the kinase-regulator measurements (Section 3.6). Surprisingly, we found a copy number
variation over four and five orders of magnitude for sensors and regulators, respectively
(Figure 3.4). The total numbers are between 200 and 24000 sensors and between 300 and
154000 regulators per cell. Remarkably, all fusions were cloned under the same ribosome
binding site and under control of the pTrc promotor. In addition, we did not use any
inducer in all experiments, the protein expression is due to the leakyness of the pTrc pro-
motor. We think the reasons for these variations are a different codon usage between the
proteins, which leads to difference in gene expression. In addition, there might be forma-
tion of mRNA secondary structures or differences in translational efficiency between the
proteins. leding to a variation in the protein copy numbers. Even though these numbers
cannot be directly used to determine the native copy numbers, we assume that large dif-
ferences between protein numbers might also occur for wildtype proteins. Additionally, as
EnvZ exhibited the lowest value in our assay, we think that 100 sensors per cell might be
a lower limit of sensor numbers for other two-component systems. We therefore adjusted
the protein expression for our further experiments to about 2000 copies for the kinases and
about 5000 copies for the regulators, except for a few constructs which showed already
higher expression levels without induction. We assume that this corresponds to about 10
fold or less protein overexpression above the native level in our FRET assays. In this range,
we can rule out false positive results because of random protein collisions or a high protein
density inside the cytoplasmic membrane, which leads to unspecific FRET interactions.
4.2 Sensor localization
Distinct localization of cellular components plays a significant role in different processes.
Similar to eukaryotes, in some cases bacteria make use of higher-order structures. Es-
pecially for components of signaling pathways, distinct protein localization could ensure
functionality of information processing and isolation against interference with other path-
ways. This holds true even though clustering might not be obvious for proteins sensing
environmental cues, which occur more or less homogenously distributed in the cell´s sor-
roundings. There are some studies performed on the localization of two-component sig-
naling components in E. coli and other bacteria such as C. crescentus and R. sphaeroides
[158, 162, 159, 92, 176, 163, 169, 111]. However, a comprehensive characterization of all
TCS present in a bacterial cell remains elusive. We therefore performed fluorescence imag-
ing experiments with YFP fusions to the sensor kinases and response regulators to identify
their localization inside the cell (Section 1.4).
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Figure 3.5 shows an overview of histidine kinase localization, and we found three differ-
ent kinds of localization pattern. A group of nine sensors showed an uniform distribution
around the cell periphery, indicating a homogenous insertion into the periplasmic mem-
brane without any spatial preference to form higher order structures (Figure 3.5a). The
distribution seems to be an intrinsic property of these sensors, as it was observed under
a variety of different conditions we tested. The largest group of sensors showed a dis-
tribution which can be described as punctuated localization, representing a homogenous
sensor arrangement with additional small clusters formed in the cytoplasmic membrane
(Figure 3.5c and Table 3.5). Some of these kinases showed punctuated localization under
all conditions tested, hinting at intrinsic protein properties responsible for the formation of
higher-order clusters. The sensors BaeS, CitA, CpxA, CusS, EnvZ and PhoQ exhibited dif-
ferent localization dependent on growth medium. One explanation could be differences in
media composition can effect localization. However, catabolite repression can be excluded
in most cases, as minimal media samples containing glucose had no effect on localization
compared to those containing glycerol. Another reason might be that protein expression
was weaker in LB compared to other media due to faster cell growth. As proteins are less
abundant, this could explain the spotted localization pattern in LB in contrast to a ho-
mogenous distribution in other media, where the sensor expression is higher. This seems to
be true for CitA, CpxA and PhoQ. Another explanation might be the changed membrane
composition upon different growth conditions. The formation of different lipid domains
might favour clustering of some sensors into specific membrane compartments. The effect
of stimulus on localization was only visible for two proteins, HydH and PhoR, suggesting
that for the majority of sensors stimulation has no effect on the spatial organization. HydH
and PhoR are involved in sensing of the bivalent cations Zn2+ and Mg2+, respectively. An
explanation might be a spatial coordination of different sensor dimers through the charge
of these ions, which might induce the formation of clusters upon stimulation. In nearly
all cases localization in wildtype and knockout cells were identical, suggesting that pres-
ence of the unlabeled sensor has no effect localization. The third localization pattern we
observed for EvgS and TorS, both exhibit a pattern of distinct protein localization mainly
at the cell poles (Figure 3.5b). The occurence of sensor clusters is independent of the
experimental conditions (Table 3.5). Since dimerization mediated by the monomeric fluo-
rophores is unlikely, localization seems to represent an intrinsic property of the proteins.
This is confirmed by additional experiments from our colloborators in the Vaknin group.
Using fluorescence polarization measurements on YFP labelled TorS and EvgS, they could
show that both protein fusions exhibited low anisotropy values (Sommer et al., in prepa-
ration and Ady Vaknin, personal communication). As fluorescence anisotropy is sensitive
93
4 Discussion
to fluorophore distance and the occurence of homo-FRET reduces steady state anisotropy
[222, 223], these results demonstrate a high affinity for molecular self-association for both
sensors. Additionally, they could confirm specificity of TorS clustering performing co-
localization studies with the cognate response regulator TorR and the periplasmic binding
protein TorT, which showed specific clustered co-localization in presence of the kinase. To
our knowledge, this localization pattern has not been reported so far in the literature. The
next question is the physiological meaning behind this sensor complex formation. TorS
senses trimethylamin-N-oxid (TMANO) and subsequently activates the torCAD operon,
encoding the TMANO anaerobic respiration system [224]. TorS is a unorthodox kinase
with a four-step phosphorelay to provide additional regulatory checkpoints [225], and is
member of a sensor subfamily including EvgS, ArcB and BvgS from Bordetella pertussis.
EvgS is involved in the acid and multidrug resistance of E. coli, but a specific stimulus
is unknown to date [114]. Bock and co-workers showed that EvgS in vitro responds to
oxidized ubiquinone-0, which is part of the electron transport chain [226]. ArcB and BvgS
are involved in switching between anaerobic and aerobic conditions and in quinone sig-
naling, respectively. Taken together, this might suggest co-localization of EvgS and TorS
to components of the respiration chain localized in the cytoplasmic membrane, which we
will try to varify in future experiments. Unfortunately, our ArcB-YFP fusion showed a
strong amount of degradation (Table 3.2), thus it was not possible to test the localization
pattern of another kinase in this subgroup. We were not able to reproduce the same lo-
calization pattern observed by Scheu and co-workers for DcuS and CitA, which showed
polar spots distinct from chemotaxis receptor clusters [169]. In our hands, CitA formed
small clusters distributed around the cell, which did not exclusively localize to the poles.
A reason for this might be a difference in the background strain, which has an effect on
the localization pattern. For DcuS we saw a homogenous localization around the cell pe-
riphery. In contrast, our collaborators saw the formation of polar regulator DcuB-YFP
clusters in presence of the unlabeled kinase (A. Vaknin, personal communication). The
explanation for this difference might be steric hindrance of the fused proteins due to the
attached fluorophores, hindering the self-association of DcuS. Taken together, our results
show that protein clustering is not only a property of protein complexes involved in cell
motility [161], it can also occur in other signaling circuits regulating metabolic processes.
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4.3 Protein interactions and promotor activation within
pathways
Sensor histidine kinases are thought to form homodimers, which are facilitated through the
cytoplasmic DHp domain located between the HAMP and CA domains. There were several
studies performed in vitro which confirmed homodimerization by providing biochemical
and structural data [39, 41, 42, 40, 43]. Noteworthy, this seems not to be the case for all
existing two-component sensors, as there is at least one example of a monomeric sensor
kinase present in B. subtilis [44].
4.3.1 Histidine kinase interactions
To verify homooligomerization for the different kinase fusions, we performed acceptor pho-
tobleaching FRET measurements on 21 different sensor pairs (Figure 3.7). We could iden-
tify a significant FRET signal for 12 of the measured pairs, which strongly indicates the
formation of dimers or higher-order oligomers between the sensors. Currently, our setup
does not provide a spatial resolution on the molecular level, and we cannot distinguish be-
tween the occurence of dimers or higher-order oligomers. To investigate this in more detail,
we will perform co-localization experiments on the positives in future experiments. The
identified interactions are likely to be specific, as we performed our experiments in wild-
type strains with expression levels of several thousand copies per cell. Only above "40000
copies sensors start to form unspecific interactions because of the density of proteins in-
serted into the membrane. This has been shown by our collaboration partner with titration
experiments using fluorescence anisotropy measurements (A. Vaknin, personal communi-
cation). There were also 9 pairs exhibiting no change in FRET, which may be due to
intrinsic structural properties of the proteins. Given the distance dependence of FRET,
energy transfer can only occur for intermolecular distances below 10 nm [192]. Therefore,
the two fluorophores might be too far apart for sensors exhibiting a large size, which pre-
vents energy transfer between YFP and CFP. To circumvent false negative results, one
possibility is to construct truncated sensor fusions, as it was successfully performed for the
chemoreceptor Tar from E. coli chemotaxis [155, 207]. One drawback might be the loss
of signaling functionality, as the DHp domain responsible for dimerization (and therefore
the best target for labelling) lies N-terminal of the catalytic ATPase domain providing
the phosphoryl group required for kinase autophosphorylation. Therefore, a C-terminal
truncation may have a negative impact on the signaling properties, but could resolve the
question about dimerization properties in vivo.
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Next, we were interested in characterizing the kinetics of conformational changes of
sensors taking place during signal transmission. Similar experiments have been performed
extensively to characterize the signaling properties of chemoreceptors in E. coli [161, 194,
227]. To fit these measurements to our needs, there are a couple of requirements which
have to be fulfilled by the systems we want to investigate. One prerequisite is a change
in FRET signal in our acceptor photobleaching setup, showing the general functionality
of the fusions. Another requirement is the availability of a defined stimulus for activating
the systems, and for the simplest application this should be a non-toxic chemical. In
addition, application of a stimulus has to induce a conformational change within the kinase
dimer, which is large enough to have an impact on the energy transfer between the two
fluorophores.
We tested a range of different kinases with a variety of stimuli documented to activate the
individual systems (Table 3.7), and identified BaeS and CitA responding to their stimuli
CuSO4 and citrate, respectively. CitA showed a very weak response to 1 and 10 mM
citrate (Figure 3.10), with the applied concentrations being in the order of magnitude
of the literature value [169]. BaeS responded to different concentrations of CuSO4 in
a concentration dependent manner between 50 nM and 30 µM of stimulus (Figure 3.9).
The clear response allowed us to measure a dose response curve of the BaeS sensor upon
stimulation, which is depicted in Figure 3.9b. From the Hill-fit applied to the measured
values, we could determine a K1/2 for the conformational change of the kinase in vivo of
about 1.2 µM. We detected a dynamic range of the signaling system between 10 nM and
10 µM. BaeS has been reported to react on 2 mM of CuSO4in a β-galactosidase assay, an
order of magnitude higher compared to our results [212]. A possible explanation might
be the higher sensitivity of the confirmational change exhibited by BaeS compared to the
donwnstream effect on gene regulation.
4.3.2 Sensor-response regulator interactions
In the next step we investigated interactions a step further in the signaling cascade, between
histidine kinases and response regulators. We focused on a subset of ten pairs and we
identified 8 kinase-regulator pairs which exhibited a change in FRET upon YFP bleaching
(Table 3.8), confirming an interaction between the sensor and regulator in vivo. Most of
these pairs displayed a change in FRET in both orientations (HK-YFP/RR-CFP and HK-
CFP/RR-YFP), strenghtening the findings as specific interactions. As expected, almost all
positives exhibited a FRET change of 1 % or more, which represents a strong interaction
for the cognate pairs.
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The 8 identified kinase-regulator pairs were subsequently tested for response to their
reported stimuli, excluding CpxAR and YedVW, as they lack well defined stimuli [228, 229].
We identified only BaeS/BaeR responding to 2 mM of indole (Figure 3.12), all other systems
displayed no response (Table 3.10). For BaeSR, further experiments are required to perform
a similar characterization of concentration-dependent protein kinetics as performed for the
sensor interactions discussed before (Figure 3.9). Surprisingly, we could not stimulate
the interaction using CuSO4 as in the stimulus dependent sensor measurements discussed
before. Also applying indole as stimulus on the sensor did not show any effect on the
kinetics. We do not have a good explanation for this difference in behaviour of the pathway
between individual experiments. It is possible that the signaling mechanisms for copper and
indole sensing are different, with distinct conformational changes of the kinase dependent
on the applied substance.
4.3.3 Promotor activation upon stimulation
As the performed stimulus dependent FRET experiments showed no responses in most
of the cases, we investigated the effect of sensor stimuli on the activity of TCS regulated
promotors. We focused on the subset of positively tested TCS depicted in the heatmap
(Figure 3.8) and investigated the promotor activation by using chemical stimuli reported
for the single systems (Table 3.12). We identified a few examples where we could mea-
sure a significant change in promotor activity (Figure 3.16). An upregulation of at least
twofold was detected for cusC (from CusSR pathway) in response to CuSO4, for ompC
(EnvZ/OmpR) responding to NaCl, for ytfE (NarXL) in response to NaNO2 and for zraP
(HydHG) increasing on ZnSO4 application. For a set of six promotors we saw a significant
decrease in promotor activity of about 50 %. These promotors include citC (from CitAB
pathway) responding to citrate, fdnG (NarQP) responding to nitrate and fumarate, glnA
(NtrB) responding to α-ketoglutarate, nrfA (NarQP) reacting on nitrite, phoA (PhoQP)
on fumarate and ygjJ (BasSR) on ferric sulfate. For these systems we now have substances
available which can be used to activate or inhibit the certain pathways, especially in fur-
ther stimulus dependent FRET experiments to study pathway dynamics of two-component
systems. Though, for the majority of investigated promotors, regulation was very weak
and in the range of the background activity without stimulus. Other promotors which are
reported to be activated or repressed by a certain pathway did not show any significant
change in their activity. This can be explained by the applied substance not acting on
the pathway as it was reported before, and would explain the negative responses in our
stimulus-dependent FRET experiments. Another explanation might be the time scale of
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the promotor response, with an application time between 30 and 45 minutes to the liquid
culture was too short to trigger an intracellular response. In some cases, negative results
might be due to the growth conditions. We incubated all samples aerobically in minimal A
medium, which might have a negative effect on the gene expression of some TCS proteins.
4.4 Pathway interconnections and cross-talk
Given the structural and functional redundancies among individual two-component sys-
tems, the possibility of interconnections between different signaling pathways is an inter-
esting question. A certain degree of cross-regulation between pathways would enable cells
to integrate signals from various sources, providing another layer of information processing
and a more sophisticated regulation of metabolic processes. There are some in vivo and
in vitro studies reporting the occurence of cross-regulation between E. coli TCS pathways
through auxiliary proteins [113, 114] and direct cross-talk [80, 134, 230, 136, 94]. However,
a systematic in vivo screen has not been performed so far.
4.4.1 Cross-talk between histidine kinases
One possibility where cross-talk between two-component pathways can take place is on the
level of histidine kinases. Therefore, we investigated the interactions between different sen-
sors using our acceptor photobleaching FRET approach. We focused on the set of kinases
which showed interactions in the dimer screen performed before (Figure 3.7). The results
are depicted in Figure 3.8. We identified 9 hetero-interactions between different sensors,
which represents 12.5 % of the tested combinations. The interacting sensor pairs are sum-
marized in Figure 4.1a. It should be mentioned that some interactions were observed in
one orientation, only. This most probably results from differences in the expression levels
between the fusions. The FRET setup is sensitive to the YFP/CFP ratio, for an effective
energy transfer between the fluorophores the number of YFP molecules should be in slight
excess compared to CFP. Otherwise, FRET occurs less efficiently, which leads to false neg-
ative results. For the identified interactions there are several possible explanations. One is
the formation of heterodimers between the different kinases. This is a real possibility given
that sensors show a high degree of structural conservation [27], and heterodimerization has
already been described for the two histidine kinases RetS and GacS from P. aeruginosa
virulence regulation [137]. Another explanation would be the formation of higher-order
complexes similar to the non-canonical two-component system in E. coli chemotaxis [161].
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These complexes are multi-protein clusters including sensors and kinases which localize
in distinct polar and lateral spots. In this case, identified interactions would represent
clustered signaling complexes between different sensor homodimers. Even though we could
not see a distinct localization pattern, we found for the pairs CpxA/CitA and CpxA/PhoQ
a spotted localization indicating possible complex formation (Figure 3.5).
a       b  
c
QseC UhpBCusSAtoS CitAYedV KdpDBasS
AtoC UhpAYedW KdpEBasR CitBCusRQseBCitAYedV
BarA
DcuS CpxA
NarQ
BaeS
QseC
PhoQ
 RcsANarQ UhpA YedV CitA      BarA CusS  PhoQ DcuS CpxA
wza csrBcitC dcuBfdnG? uhpTcusC phoAhtrA
Figure 4.1: Overview in vivo cross-talk between two-component systems. (a) Cross-talk be-
tween different sensor kinases identified using acceptor photobleaching FRET. Node colour
represents degree of interconnection, increasing from green to red. Blue edges show in-
teractions, red edges represent interactions confirmed with stimulus dependent FRET. (b)
Kinase-regulator cross-talk from acceptor photobleaching FRET experiments. Circles rep-
resent sensors, squares represent regulators. Blue edges show identified interactions. (c)
Cross-talk on non-cognate promotors, determined by complementation and overexpression
screens using flow cytometry. Circles represent sensors, letters represent promotors. Blue
edges show identified (cross-)regulation. Networks were visualized using Cytoscape [231].
Noteworthy, we cannot distinguish between the formation of dimers or higher-order
complexes in our setup due to the limitation in spatial resolution. To examine this fur-
ther experiments are required, for example the investigation of co-localization between the
different sensors. Where available or identified (Figure 3.16), we tested chemical stimuli
on the sensor hetero-pairs established in the cross-talk screen. We found a response for
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the two pairs CitA/CpxA and CpxA/PhoQ (Figure 3.11). In both cases, we did not use
a stimulus for CpxA, as envelope protein misfolding is difficult to apply in a quantitative
way and different pH values change fluorescence signals during our FRET measurements.
Using citrate and MgSO4, respectively, both pairs showed a specific response in sensor-
sensor interactions (Figure 3.11b). It is not clear why the other pairs did not respond
in our setup. Sensors might not perform a large conformational change upon stimulation
which is required for FRET, or the reported stimuli may have no effects on the pathways
(as discussed above).
As confirmation of the results from FRET experiments, we could verify the physiolog-
ical relevance of sensor interactions in the case of DcuS/NarQ, DcuS/PhoQ, DcuS/BarA
and CitA/CpxA (summarized in Figure 4.1c). We confirmed a significant effect on the
non-cognate promotor activity in kinase knockouts (Figure 3.15), and after complemen-
tation with the kinase-fusion wildtype promotor activity recovered. These experiments
will be expanded by testing cross-regulation on the promotor level using stimulation. The
physiological meaning behind the identified interactions is not obvious for all pairs, as
involved sensors react to a variety of signals (including bivalent cations, nitrate and ni-
trite, C4-dicarboxylates, cell density, protein folding) or a defined stimulus is not known.
However, for the kinases NarQ and DcuS an interconnection is plausible, as they regulate
the frd operon encoding a fumarate reductase [230] and the fumarate respiratory gene
dcuB, respectively[232]. Under anaerobic conditions, this might provide a mechanism for
adjustment of the metabolism dependent on the availability of fumarate. CpxA and PhoQ
regulate expression of the protein folding/degradation gene htrA and the pag operon for
antimicrobial peptides, respectively [233, 234, 235]. Therefore, the physiological connection
between the pathways despite their involvelment in stress response ist not clear .
Taken together, we were able to identify some interactions between pathways on the
sensor level, which seem to be of physiological relevance. Nevertheless, there is a demand
for further experiments to elucidate the detailed molecular mechanisms, and the remaining
histidine kinases should be included to draw a comprehensive picture.
4.4.2 Cross-talk between sensors and response regulators
To extend our knowledge of the E. coli two-component network, we investigated cross-
interactions between non-cognate histidine kinases and response regulators, which has been
previously described in vitro for a few systems [80, 134, 230, 136, 94]. We chose a subset of
sensor-regulator-pairs based on two available sources: identified proteins which performed
cross-phosphorylation in vitro [136] and in silico predictions of interaction probabilites from
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the van Nimwegen group ([127] and Erik van Nimwegen, personal communication). All
combinations were tested in the orientation HK-CFP/RR-YFP, as CFP-fusion constructs
are under control of a pBAD promotor, which enables tighter regulation of expression in
contrast to the pTrc promotor controlling the YFP-constructs [200]. As regulators are more
abundant compared to kinases, stronger leakiness in regulator-expression from the pTrc
promotor should not have an impact on the FRET experiments favoured by the higher
ratio of YFP to CFP.
Within the 38 interactions tested, we were able to identify six pairs exhibiting cross-talk
between a kinase and a non-cognate regulator (summarized in Figure 4.1b). The reason for
this small number of positives might be due to conceptual differences between the in vitro
experiments/in silico predictions and our investigations. Yamamoto and co-workers used
a phosphorylation assay with purified cytoplasmic kinase domains, only. As there is most
likely an effect of the membrane on the sensor´s orientation, this might structurally inhibit
cross-talk to non-cognate response regulators in vivo. In addition, the phosphorylation
of purified proteins in vitro is probably more efficient compared to the one in vivo. The
computational predictions rated the interaction probability between different TCS proteins,
and are based on the co-variation of amino acids located in their interaction interfaces. The
approach is therefore not able to depict the cellular environment in all details which might
interfere with interactions.
For some identified cross-talk we have a possible physiological explanation. UhpB is
a sensor for glucose-6-phosphate [220], and regulates the uhpT gene responsible for hex-
osephosphate uptake. CitB is involved in sensing of citrate and regulation of the cit operon
for anaerobic citrate fermentation [236]. This connection might play a role in metabolic
fine tuning dependent on the availability of energy sources under aerobic or anaerobic
concditions. YedVW is a predicted two-component system, which function or stimuli are
not well known, but may be involved in the E. coli metal homeostasis [136]. This is in
agreement with our findings, showing an interconnection with the copper resistance system
CusSR. We confirmed this pathway interconnection on the promotor level, as the YedV
kinase has an influence on the cusC promotor (discussed below). In addition, the Vaknin
group found that YedV responded to Cu2+ in their fluorescence anisotropy measurements
(A. Vaknin, personal communication). Taken together, these results strongly suggests an
interconnection between the two pathways, which provides a premise for further investiga-
tions.
101
4 Discussion
4.4.3 Effects of cross-talk on gene expression
To verify and expand the list of cross-talking candidates identified in the FRET screens
(Figure 3.8), we performed experiments involving the input and output of the pathways,
i.e. sensor kinase and downstream promotor. We tested the effect of kinase overexpression
on the activity of cognate and non-cognate promotors. These experiments are motivated
by the sensor´s intrinsic kinase and phosphatase property [237]. Either these reactions can
be increased by sensor overexpression, changing the ratio between kinase and regulator.
Subsequently, this should lead to a change in transcriptional activity. This change in gene
expression in dependence on phosphorylated RR concentration has been described earlier
for various bacteria [79, 238, 239]. Additionally, it has been shown that the amount of
cross-talk increases with sensor overexpression [80].
The results of kinase overexpression are depicted in Figure 3.13. We observed that,
except the combinations DcuS/dcuB and NtrB/glnA, we could not detect any significant
change in promotor activity upon overexpression of the cognate sensors as expected. The
reason for this is probably the ratio between the sensor´s kinase and phosphatase activity,
which might not change upon protein overexpression for some of the sensors. Additionally,
the effects of kinase knockouts on promotor activity were stronger in contrast to kinase
overexpression (Figure 3.15). Even though the cognate combinations did not show a general
response, we identified three cases of non-cognate activation upon kinase overexpression
(summarized in Figure 4.1c). YedV activated the cusC promotor from the copper resistance
system CusSR [214], and relevance of this interaction could be confirmed by the HK-RR
cross-talk results already discussed before. The strongest cross-activation was exhibited
between NarQ from anaerobic respiration on uhpT from the glucose-6-phosphate sensing
system UhpAB. This connection might reflect a metabolic fine-tuning dependent on the
availability of oxygen. The promotor wza from the RcsAB system was strongly activated
by PhoQ, but the physiological implication for this cross-talk between capsule synthesis
and magnesium starvation pathways remains unclear.
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The majority of prokaryotes use two-component signaling systems to sense a variety of
intra- end extracellular signals. In this work we were able to characterize the spatial
organization of sensor kinases and the interconnections between signaling pathways on
different levels.
We found that most of the sensors exhibit a intrinsic tendency for cluster formation,
which might provide a scaffold for information processing and insulates pathways against
detrimental noise from other sources. For kinases, we could confirm the formation of
sensor dimers or higher order oligomers in vivo for most of the two-component systems.
For the sensor BaeS, we characterized the change of sensor confirmation upon stimulation.
In addition, we identified two histidine kinases, TorS and EvgS, which exhibit a spotted
localization pattern similar to those found for other multiprotein complexes like chemotaxis
clusters. These results suggest the possibility, that clustering of histidine kinases can be
beneficial not only for motility control, but plays moreover a role in the regulation of gene
expression. Further experiments are required to uncover the nature of cluster formation
in these cases. Co-localization studies on sensors will show if different kinases cluster into
the same complexes, and the stability of kinase clusters will be investigated using FRAP
(Fluorescence Recovery After Photobleaching) microscopy.
We found, at least within the tested pairs, a high degree of specificity between intra-
cellular signaling circuits in E. coli, as it was already proposed in the literature. This
is a necessity against detrimental interactions, interfering with proper signal transmission
inside the cell. Nevertheless, we identified a few pathways exhibiting interconnections on
the sensor level and between sensors and non-cognate regulators, providing an additional
layer of information processing. Some of these pathway interconnections seem to be phys-
iologically meaningful as we could show effects on the level of gene expression. For other
systems, these experiments will be expanded with tests of cross-regulation on the pro-
motor level using kinase knockouts and/or pathway stimulation. In addition, the screens
for kinase-kinase and kinase-regulator inteactions will be expanded on all two-component
system to draw a comprehensive picture of E. coli signaling.
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Table 6.1: Plasmids used in this study.
Plasmid Vector Gene(s) Cloning sites Marker Induction ORI Source/reference
- pUA66 asr-gfp XhoI, BamH I kan - pSC101 [185]
- pUA66 creA-gfp XhoI, BamH I kan - pSC101 [185]
- pUA66 ygjJ-gfp XhoI, BamH I kan - pSC101 [185]
- pUA66 tdcB-gfp XhoI, BamH I kan - pSC101 [185]
pACBSR - I-SceI, λ
Red
- cam ara p15A [202]
pAE-1 pTrc99A cusS-yfp NcoI, BamH I amp IPTG pBR this work
pAM90 pUA66 citC-gfp XhoI, BamH I kan - pSC101 this work
pAM91 pUA66 fdnG-gfp XhoI, BamH I kan - pSC101 this work
pAM92 pUA66 frdA-gfp XhoI, BamH I kan - pSC101 this work
pAM93 pUA66 sdhC-gfp XhoI, BamH I kan - pSC101 this work
pAM95 pUA66 glnA-gfp XhoI, BamH I kan - pSC101 this work
pAM96 pUA66 cusC-gfp XhoI, BamH I kan - pSC101 this work
pAM97 pUA66 uhpT-gfp XhoI, BamH I kan - pSC101 this work
pAM100 pUA66 citT-gfp XhoI, BamH I kan - pSC101 this work
pAM101 pUA66 zraP-gfp XhoI, BamH I kan - pSC101 this work
pAM103 pUA66 mdtA-gfp XhoI, BamH I kan - pSC101 this work
pAM104 pUA66 flhD-gfp XhoI, BamH I kan - pSC101 this work
pAM106 pUA66 pstS-gfp XhoI, BamH I kan - pSC101 this work
pAM107 pUA66 ompC-gfp XhoI, BamH I kan - pSC101 this work
pAM108 pUA66 phoA-gfp XhoI, BamH I kan - pSC101 this work
pAM110 pUA66 htrA-gfp XhoI, BamH I kan - pSC101 this work
pAM111 pUA66 nrfA-gfp XhoI, BamH I kan - pSC101 this work
125
Appendix
Plasmid Vector Gene(s) Cloning sites Marker Induction ORI Source/reference
pAM102 pUA66 dcuB-gfp XhoI, BamH I kan - pSC101 this work
pES165 pBAD33 ntrC-cfp SpeI, HindIII cam ara pACYC this work
pAM113 pUA66 ytfE-gfp XhoI, BamH I kan - pSC101 this work
pBAD33 - expression MCS cam ara pACYC [200]
plasmid
pCP20 pMMC6 FLP+ - amp, cam - Repts [199]
pDK-112 pTrc99A frontlinker-
yfp
NcoI, BamH I amp IPTG pBR D. Kentner
pDK-113 pTrc99A frontlinker-
cfp
NcoI, BamH I amp IPTG pBR D. Kentner
pES15 pTrc99A cheY-
venus
SacI, XbaI amp IPTG pBR this work
pES16 pTrc99A cheY-
mCherry
SacI, XbaI amp IPTG pBR this work
pES17 pBAD33 cheZ-
cerulean
SacI, XbaI cam ara pACYC this work
pES18 pTrc99A cheY-
YPet
SacI, XbaI amp IPTG pBR this work
pES19 pBAD33 cheZ-
CyPet
SacI, XbaI cam ara pACYC this work
pES20 pTrc99A baeS-yfp NcoI, BamH I amp IPTG pBR this work
pES21 pTrc99A uhpB-yfp NcoI, BamH I amp IPTG pBR this work
pES22 pTrc99A phoR-yfp NcoI, BamH I amp IPTG pBR this work
pES24 pTrc99A qseC-yfp NcoI, BamH I amp IPTG pBR this work
pES25 pTrc99A dcuS-yfp NcoI, BamH I amp IPTG pBR this work
pES26 pTrc99A rstB-yfp NcoI, BamH I amp IPTG pBR this work
pES27 pTrc99A envZ-yfp NcoI, BamH I amp IPTG pBR this work
pES28 pTrc99A cpxA-yfp NcoI, BamH I amp IPTG pBR this work
pES30 pTrc99A yedV-yfp NcoI, BamH I amp IPTG pBR this work
pES31 pTrc99A ypdA-yfp NcoI, BamH I amp IPTG pBR this work
pES32 pTrc99A narQ-yfp NcoI, BamH I amp IPTG pBR this work
pES33 pTrc99A narX-yfp NcoI, BamH I amp IPTG pBR this work
pES34 pTrc99A creC-yfp NcoI, BamH I amp IPTG pBR this work
pES35 pTrc99A ntrB-yfp NcoI, BamH I amp IPTG pBR this work
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Plasmid Vector Gene(s) Cloning sites Marker Induction ORI Source/reference
pAM102 pUA66 dcuB-gfp XhoI, BamH I kan - pSC101 this work
pES165 pBAD33 ntrC-cfp SpeI, HindIII cam ara pACYC this work
pES37 pTrc99A citA-yfp NcoI, BglII amp IPTG pBR this work
pES38 pTrc99A basS-yfp NcoI, BamH I amp IPTG pBR this work
pES39 pTrc99A yfhk-yfp NcoI, BamH I amp IPTG pBR this work
pES40 pTrc99A atoS-yfp NcoI, BamH I amp IPTG pBR this work
pES41 pTrc99A kdpD-yfp NcoI, BamH I amp IPTG pBR this work
pES42 pTrc99A torS-yfp NcoI, BamH I amp IPTG pBR this work
pES43 pTrc99A phoQ-yfp NcoI, BamH I amp IPTG pBR this work
pES44 pTrc99A arcB-yfp BspH I, BamH I amp IPTG pBR this work
pES45 pTrc99A lytS-yfp NcoI, BamH I amp IPTG pBR this work
pES46 pTrc99A barA-yfp NcoI, BamH I amp IPTG pBR this work
pES47 pTrc99A baeS-cfp NcoI, BamH I amp IPTG pBR this work
pES48 pTrc99A uhpB-cfp NcoI, BamH I amp IPTG pBR this work
pES49 pTrc99A phoR-cfp NcoI, BamH I amp IPTG pBR this work
pES50 pTrc99A evgS-yfp NcoI, BamH I amp IPTG pBR this work
pES51 pTrc99A qseC-cfp NcoI, BamH I amp IPTG pBR this work
pES52 pTrc99A dcuS-cfp NcoI, BamH I amp IPTG pBR this work
pES53 pTrc99A cusS-cfp NcoI, BamH I amp IPTG pBR this work
pES55 pTrc99A rstB-cfp NcoI, BamH I amp IPTG pBR this work
pES56 pTrc99A envZ-cfp NcoI, BamH I amp IPTG pBR this work
pES57 pTrc99A cpxA-cfp NcoI, BamH I amp IPTG pBR this work
pES58 pTrc99A yedV-cfp NcoI, BamH I amp IPTG pBR this work
pES59 pTrc99A hydH-cfp NcoI, BamH I amp IPTG pBR this work
pES60 pTrc99A ypdA-cfp NcoI, BamH I amp IPTG pBR this work
pES61 pTrc99A narQ-cfp NcoI, BamH I amp IPTG pBR this work
pES62 pTrc99A narX-cfp NcoI, BamH I amp IPTG pBR this work
pES63 pTrc99A creC-cfp NcoI, BamH I amp IPTG pBR this work
pES64 pTrc99A ntrB-cfp NcoI, BamH I amp IPTG pBR this work
pES65 pTrc99A citA-cfp NcoI, BamH I amp IPTG pBR this work
pES66 pTrc99A basS-cfp NcoI, BamH I amp IPTG pBR this work
pES67 pTrc99A yfhK-cfp NcoI, BamH I amp IPTG pBR this work
pES68 pTrc99A atoS-cfp NcoI, BamH I amp IPTG pBR this work
pES70 pTrc99A torS-cfp NcoI, BamH I amp IPTG pBR this work
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Plasmid Vector Gene(s) Cloning sites Marker Induction ORI Source/reference
pAM102 pUA66 dcuB-gfp XhoI, BamH I kan - pSC101 this work
pES165 pBAD33 ntrC-cfp SpeI, HindIII cam ara pACYC this work
pES71 pTrc99A phoQ-cfp NcoI, BamH I amp IPTG pBR this work
pES72 pTrc99A arcB-cfp SpeI, BamH I amp IPTG pBR this work
pES73 pTrc99A lytS-cfp NcoI, BamH I amp IPTG pBR this work
pES74 pTrc99A barA-cfp NcoI, BamH I amp IPTG pBR this work
pES75 pBAD33 baeS-cfp SpeI, HindIII cam ara pACYC this work
pES76 pBAD33 uhpB-cfp SpeI, HindIII cam ara pACYC this work
pES77 pBAD33 phoR-cfp SpeI, HindIII cam ara pACYC this work
pES78 pTrc99A evgS-cfp NcoI, BamH I amp IPTG pBR this work
pES79 pBAD33 qseC-cfp SpeI, HindIII cam ara pACYC this work
pES80 pBAD33 dcuS-cfp SpeI, HindIII cam ara pACYC this work
pES81 pBAD33 cusS-cfp SpeI, HindIII cam ara pACYC this work
pES83 pBAD33 envZ-cfp SpeI, HindIII cam ara pACYC this work
pES84 pBAD33 hydH-cfp SpeI, HindIII cam ara pACYC this work
pES85 pBAD33 ypdA-cfp SpeI, HindIII cam ara pACYC this work
pES86 pBAD33 narQ-cfp SpeI, HindIII cam ara pACYC this work
pES87 pBAD33 yedV-cfp SpeI, HindIII cam ara pACYC this work
pES88 pBAD33 creC-cfp SpeI, HindIII cam ara pACYC this work
pES89 pBAD33 narX-cfp SpeI, HindIII cam ara pACYC this work
pES90 pBAD33 ntrB-cfp SpeI, HindIII cam ara pACYC this work
pES91 pBAD33 basS-cfp SpeI, HindIII cam ara pACYC this work
pES92 pBAD33 yfhK-cfp SpeI, HindIII cam ara pACYC this work
pES93 pBAD33 phoQ-cfp SpeI, HindIII cam ara pACYC this work
pES94 pBAD33 cpxA-cfp SpeI, HindIII cam ara pACYC this work
pES95 pBAD33 rstB-cfp SpeI, HindIII cam ara pACYC this work
pES96 pBAD33 atoS-cfp SpeI, HindIII cam ara pACYC this work
pES97 pBAD33 barA-cfp SpeI, HindIII cam ara pACYC this work
pES101 pBAD33 arcB-cfp SpeI, HindIII cam ara pACYC this work
pES102 pBAD33 torS-cfp SpeI, HindIII cam ara pACYC this work
pES103 pTrc99A ompR-yfp NcoI, BamH I amp IPTG pBR this work
pES104 pTrc99A arcA-yfp NcoI, BamH I amp IPTG pBR this work
pES105 pTrc99A kdpE-yfp NcoI, BglII amp IPTG pBR this work
pES107 pTrc99A torR-yfp NcoI, BamH I amp IPTG pBR this work
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Plasmid Vector Gene(s) Cloning sites Marker Induction ORI Source/reference
pAM102 pUA66 dcuB-gfp XhoI, BamH I kan - pSC101 this work
pES165 pBAD33 ntrC-cfp SpeI, HindIII cam ara pACYC this work
pES108 pTrc99A phoP-yfp NcoI, BamH I amp IPTG pBR this work
pES109 pTrc99A phoB-yfp NcoI, BamH I amp IPTG pBR this work
pES110 pTrc99A cusR-yfp NcoI, BamH I amp IPTG pBR this work
pES111 pTrc99A basR-yfp NcoI, BamH I amp IPTG pBR this work
pES112 pTrc99A citB-yfp NcoI, BamH I amp IPTG pBR this work
pES113 pTrc99A evgA-yfp NcoI, BamH I amp IPTG pBR this work
pES114 pTrc99A qseB-yfp NcoI, BamH I amp IPTG pBR this work
pES115 pTrc99A cpxR-yfp NcoI, BamH I amp IPTG pBR this work
pES116 pTrc99A ypdB-yfp NcoI, BglII amp IPTG pBR this work
pES117 pTrc99A creB-yfp NcoI, BamH I amp IPTG pBR this work
pES119 pTrc99A uhpA-yfp NcoI, BamH I amp IPTG pBR this work
pES120 pTrc99A rstA-yfp NcoI, BamH I amp IPTG pBR this work
pES121 pTrc99A fimZ-yfp NcoI, BglII amp IPTG pBR this work
pES122 pTrc99A uvrY-yfp BspH I, BglII amp IPTG pBR this work
pES123 pTrc99A rcsB-yfp NcoI, BglII amp IPTG pBR this work
pES125 pTrc99A evgA-cfp NcoI, BamH I amp IPTG pBR this work
pES127 pTrc99A arcA-cfp NcoI, BamH I amp IPTG pBR this work
pES128 pTrc99A torR-cfp NcoI, BamH I amp IPTG pBR this work
pES129 pTrc99A phoP-cfp NcoI, BamH I amp IPTG pBR this work
pES130 pTrc99A phoB-cfp NcoI, BamH I amp IPTG pBR this work
pES131 pTrc99A basR-cfp NcoI, BamH I amp IPTG pBR this work
pES132 pTrc99A cpxR-cfp NcoI, BamH I amp IPTG pBR this work
pES133 pBAD33 evgA-cfp SpeI, HindIII cam ara pACYC this work
pES134 pTrc99A rstA-cfp NcoI, BamH I amp IPTG pBR this work
pES135 pTrc99A yedW-yfp NcoI, BamH I amp IPTG pBR this work
pES136 pTrc99A citB-cfp NcoI, BamH I amp IPTG pBR this work
pES137 pTrc99A creB-cfp NcoI, BamH I amp IPTG pBR this work
pES138 pTrc99A cusR-cfp NcoI, BamH I amp IPTG pBR this work
pES139 pTrc99A ompR-cfp NcoI, BamH I amp IPTG pBR this work
pES140 pTrc99A qseB-cfp NcoI, BamH I amp IPTG pBR this work
pES141 pTrc99A yedW-cfp NcoI, BamH I amp IPTG pBR this work
pES142 pTrc99A dcuR-yfp NcoI, BglII amp IPTG pBR this work
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Plasmid Vector Gene(s) Cloning sites Marker Induction ORI Source/reference
pAM102 pUA66 dcuB-gfp XhoI, BamH I kan - pSC101 this work
pES165 pBAD33 ntrC-cfp SpeI, HindIII cam ara pACYC this work
pES143 pTrc99A dcuR-cfp NcoI, BglII amp IPTG pBR this work
pES144 pBAD33 arcA-cfp SpeI, HindIII cam ara pACYC this work
pES145 pBAD33 torR-cfp SpeI, HindIII cam ara pACYC this work
pES146 pBAD33 phoP-cfp SpeI, HindIII cam ara pACYC this work
pES147 pBAD33 basR-cfp SpeI, HindIII cam ara pACYC this work
pES148 pBAD33 qseB-cfp SpeI, HindIII cam ara pACYC this work
pES149 pBAD33 yedW-cfp SpeI, HindIII cam ara pACYC this work
pES150 pTrc99A narP-yfp NcoI, BglII amp IPTG pBR this work
pES153 pBAD33 citB-cfp SpeI, HindIII cam ara pACYC this work
pES154 pBAD33 ompR-cfp SpeI, HindIII cam ara pACYC this work
pES155 pTrc99A uvrX-cfp BspHI, BamH I amp IPTG pBR this work
pES156 pBAD33 citA-cfp SpeI, HindIII cam ara pACYC this work
pES159 pBAD33 cpxR-cfp SpeI, HindIII cam ara pACYC this work
pES160 pBAD33 uvrY-cfp SpeI, HindIII cam ara pACYC this work
pES163 pTrc99A ntrC-yfp NcoI, BglII amp IPTG pBR this work
pES164 pTrc99A ntrC-cfp NcoI, BglII amp IPTG pBR this work
pES166 pTrc99A narL-yfp NcoI, BamH I amp IPTG pBR this work
pES170 pTrc99A rssB-yfp NcoI, BamH I amp IPTG pBR this work
pES171 pTrc99A baeR-cfp NcoI, BamH I amp IPTG pBR this work
pKD13 - rpsB,
YFP,
multiple amp, kan - R6Kgamma A. Mogk
kanR, tsf
pKD46 - λ Red - amp ara R101 [197]
pTrc99A - expression MCS amp IPTG pBR [209]
plasmid
130
Table 6.3: Primers used in this study. Restriction sites in nucleotide sequences are underlined.
Primer Nucleotide sequence (5´-3´) Restriction site Target Source
ERI14 GTAACTTCTAGACTTG
TACAGCTCGTCC
XbaI reverse fusion PCR primer XFP
+ variants C-terminal fusions
this work
ERI15 CCGGACAGGAGCTCC
GTATTTAAATC
SacI sense fusion PCR primer CheY
C-terminal fusion
this work
ERI16a GGCGGAGGAGTGTC
TAAAGGTGAAG
- sense fusion PCR primer YPet
C-terminal fusion to CheY
this work
ERI17 GGAGGCGGAGGCGGA
GTGTCTAAAGGTGAAG
- sense fusion PCR primer CyPet
C-terminal fusion to CheZ
this work
ERI19a ATATACCATGGTGCT
GGAAC GGCTGTC
NcoI sense primer phoR His-kinase
C-terminal XFP fusions
this work
ERI19b TATATGGATCCATCG
CTGTTTTTGGC
BamH I reverse primer phoR His-kinase
C-terminal XFP fusions
this work
ERI20a ATATACCATGGTGAA
AAAACTGTTTATCC
NcoI sense primer rstB His-kinase
C-terminal XFP fusions
this work
ERI20b TATATGGATCCGCAG
AGGTAAATTGC
BamH I reverse primer rstB His-kinase
C-terminal XFP fusions
this work
ERI21a ATATACCATGGTGAG
GCGATTGCGCTTC
NcoI sense primer envZ His-kinase
C-terminal XFP fusions
this work
ERI21b TATATGGATCCCCCT
TCTTTTGTCGTGCC
BamH I reverse primer envZ His-kinase
C-terminal XFP fusions
this work
ERI22a ATATACCATGGTGAT
AGGCAGCTTAACC
NcoI sense primer cpxA His-kinase
C-terminal XFP fusions
this work
ERI22b TATATGGATCCACTC
CGCTTATACAGCGG
BamH I reverse primer cpxA His-kinase
C-terminal XFP fusions
this work
ERI23a ATATACCATGGTGAAA
AGACTATCTATAACC
NcoI sense primer yedV His-kinase
C-terminal XFP fusions
this work
ERI23b TATATGGATCCATTT
CTTTGCGGTAACG
BamH I reverse primer yedV His-kinase
C-terminal XFP fusions
this work
ERI24a ATATACCATGGTGC
GTTTTATGCAACG
NcoI sense primer hydH His-kinase
C-terminal XFP fusions
this work
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ERI24b TATATGGATCCTCCT
TGTGGGTCCTTACG
BamH I reverse primer hydH His-kinase
C-terminal XFP fusions
this work
ERI25a ATATACCATGGTGT
TGCAGCTTAACGAG
NcoI sense primer citA His-kinase
C-terminal XFP fusions
this work
ERI26a ATATACCATGGTGA
GACATTCATTGCCC
NcoI sense primer dcuS His-kinase
C-terminal XFP fusions
this work
ERI26b TATATGGATCCTCT
GTTCGACCTCTCCC
BamH I reverse primer dcuS His-kinase
C-terminal XFP fusions
this work
ERI27b ATATACCATGGTGT
CGATTTTAATCTGG
NcoI sense primer lytS His-kinase
C-terminal XFP fusions
this work
ERI28a ATATACCATGGTGGTG
CACGAAATATTCAAC
NcoI sense primer ypdA His-kinase
C-terminal XFP fusions
this work
ERI28b TATATGGATCCAAGCA
ATAACGTAGCCTGTG
BamH I reverse primer ypdA His-kinase
C-terminal XFP fusions
this work
ERI29a ATATACCATGGTGCT
TAAACGTTGTCTC
NcoI sense primer narX His-kinase
C-terminal XFP fusions
this work
ERI29b TATATGGATCCCTCA
TGGGTATCTCCTTG
BamH I reverse primer narX His-kinase
C-terminal XFP fusions
this work
ERI30a ATATACCATGGTGAT
TGTTAAACGACCC
NcoI sense primer narQ His-kinase
C-terminal XFP fusions
this work
ERI30b TATATGGATCCCATT
AACTGACTTTCCTC
BamH I reverse primer narQ His-kinase
C-terminal XFP fusions
this work
ERI31 TCGGTGCCGGTTGA
TAAGGT
- sequencing primer rcsC (sense) this work
ERI32 TATATAGATCTACGA
TCAATAGGGTTAATG
BglII reverse primer citA His-kinase
C-terminal XFP fusions
this work
ERI33 GCAAAGCCGGTGTGG - sequencing primer binding to CheZ
(sense)
this work
ERI34a ATATACCATGGGTCA
TTTTCTGCGCCG
NcoI sense primer basS His-kinase
C-terminal XFP fusions
this work
ERI34b TATATGGATCCTATC
TGGTTTGCCACGTAC
BamH I reverse primer basS His-kinase
C-terminal XFP fusions
this work
ERI35a ATATACCATGGTGCG
TATCGGCATGCGG
NcoI sense primer creC His-kinase
C-terminal XFP fusions
this work
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ERI35b TATATGGATCCTGTG
AAGTGACGGTGAAG
BamH I reverse primer creC His-kinase
C-terminal XFP fusions
this work
ERI36a ATATACCATGGTGGC
AACAGGCACGCAG
NcoI sense primer ntrB His-kinase
C-terminal XFP fusions
this work
ERI36b TATATGGATCCTTTC
CTGATAGGCAGG
BamH I reverse primer ntrB His-kinase
C-terminal XFP fusions
this work
ERI37a ATATACCATGGTGAAA
CGCTGGCCCGTTTTTC
NcoI sense primer yfhK His-kinase
C-terminal XFP fusions
this work
ERI37b TATATGGATCCTTTC
GTGTTTTTCGACGAC
BamH I reverse primer yfhK His-kinase
C-terminal XFP fusions
this work
ERI40a ATATACCATGGTGAA
TAACGAACCCTTAC
NcoI sense primer kdpD His-kinase
C-terminal XFP fusions
this work
ERI40b TATATGGATCCCATA
TCCTCATGAAATTC
BamH I reverse primer kdpD His-kinase
C-terminal XFP fusions
this work
ERI41a ATATACCATGGTGAA
TTTAACCCTGACC
NcoI sense primer torS His-kinase
C-terminal XFP fusions
this work
ERI41b TATATGGATCCAATC
GCGTTCAGGTCTTTC
BamH I reverse primer torS His-kinase
C-terminal XFP fusions
this work
ERI42b TATATGGATCCTTCA
TCTTTCGGCGCAG
BamH I reverse primer phoQ His-kinase
C-terminal XFP fusions
this work
ERI43a ATATATCATGATCAA
GCAAATTCGTCTGC
BspH I sense primer arcB His-kinase
C-terminal XFP fusions
this work
ERI43b TATATGGATCCTTTT
TTAGTGGCTTTTGCC
BamH I reverse primer arcB His-kinase
C-terminal XFP fusions
this work
ERI44a ATATACCATGGTGAC
CAACTACAGCCTG
NcoI sense primer barA His-kinase
C-terminal XFP fusions
this work
ERI44b TATATGGATCCCCC
GAGAATTTTGCTGG
BamH I reverse primer barA His-kinase
C-terminal XFP fusions
this work
ERI45a ATATACCATGGTGAA
GTTTTTACCCTATAT
NcoI sense primer evgS His-kinase
C-terminal XFP fusions
this work
ERI45b TATATGGATCCGTCA
TTTTTCTGACAG
BamH I reverse primer evgS His-kinase
C-terminal XFP fusions
this work
ERI46a ATATACCATGGTGC
ATTATATGAAGTGG
NcoI sense primer atoS His-kinase
C-terminal XFP fusions
this work
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ERI46b TATATGGATCCTACA
GTCTGATTTCCCTG
BamH I reverse primer atoS His-kinase
C-terminal XFP fusions
this work
ERI47 GTAACTACTAGTTTT
GTACAATTCATCC
SpeI reverse primer CyPet, C-terminal
CheZ fusion (fusion PCR)
this work
ERI48 GAAGAGATGCAG
CACAATAT
- sequencing primer barA (sense) this work
ERI49 GACCGCGTGGGT
AAACGTC
- sequencing primer arcB (sense) this work
ERI50 TGCGCGCCTGGC
GGGGGCATC
- sequencing primer kdpD (sense) this work
ERI51 CAGCTCAATAATG
CGGTG
- sequencing primer o torS (sense) this work
ERI52 CCGCGTCAATATA
ATTTTTTC
- sequencing primer evgS (sense) this work
ERI53a ATATACCATGGCAG
CGAGACGTATTCTG
NcoI sense primer phoB response
regulator, C-terminal XFP fusions
this work
ERI53b TATATGGATCCAAAG
CGGGTTGAAAAACG
BamH I reverse primer phoB response
regulator, C-terminal XFP fusions
this work
ERI54a ATATACCATGGCAAC
AAACGTTCTGATTG
NcoI sense primer kdpE response
regulator, C-terminal XFP fusions
this work
ERI54b TATATAGATCTAAGC
ATAAACCGATAGCC
BglII reverse primer kdpE response
regulator, C-terminal XFP fusions
this work
ERI55a ATATACCATGGCACCA
CATCACATTGTTATTG
NcoI sense primer torR response
regulator, C-terminal XFP fusions
this work
ERI55b TATATGGATCCGCAC
ACATCAGCGGCTAAG
BamH I reverse primer torR response
regulator, C-terminal XFP fusions
this work
ERI56a ATATACCATGGCACGC
GTACTGGTTGTTGAAG
NcoI sense primer phoP response
regulator, C-terminal XFP fusions
this work
ERI56b TATATGGATCCGCGC
AATTCGAACAGATAG
BamH I reverse primer phoP response
regulator, C-terminal XFP fusions
this work
ERI57a ATATACCATGGCAAAT
GTTATGAACACTATC
NcoI sense primer rstA response
regulator, C-terminal XFP fusions
this work
ERI57b TATATGGATCCTTCC
CATGCATGAGGCGC
BamH I reverse primer rstA response
regulator, C-terminal XFP fusions
this work
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ERI58b TATATGGATCCAACG
ATGCGGCAGGCGTC
BamH I reverse primer baeR response
regulator, C-terminal XFP fusions
this work
ERI59a ATATACCATGGCACAGA
CCCCGCACATTCTTATC
NcoI sense primer arcA response
regulator, C-terminal XFP fusions
this work
ERI59b TATATGGATCCATCT
TCCAGATCACCGC
BamH I reverse primer arcA response
regulator, C-terminal XFP fusions
this work
ERI60a ATATACCATGGCACAA
GAGAACTACAAGATTC
NcoI sense primer ompR response
regulator, C-terminal XFP fusions
this work
ERI60b TATATGGATCCTGCT
TTAGAGCCGTCCGG
BamH I reverse primer ompR response
regulator, C-terminal XFP fusions
this work
ERI61 TACGACCATGGCGAA
AAAATTACTGCGTCTT
NcoI sense primer phoQ His-kinase,
C-terminal XFP fusions
this work
ERI62 ACTGACTCTGGTGA
ATCG
- sequencing primer torS II (sense) this work
ERI63 CGTAGTCGCACTGA
TGGC
- sequencing primer torS III (sense) this work
ERI64a TACGACCATGGCAAA
TAAAATCCTGTTAG
NcoI sense primer cpxR response
regulator C-terminal XFP fusions
this work
ERI64b TATATGGATCCTGA
AGCAGAAACCATC
BamH I reverse primer cpxR response
regulator C-terminal XFP fusions
this work
ERI65a TACGACCATGGCAAA
AATTCTGATTGTTG
NcoI sense primer basR response
regulator C-terminal XFP fusions
this work
ERI65b TATATGGATCCGTTT
TCCTCATTCGCG
BamH I reverse primer basR response
regulator C-terminal XFP fusions
this work
ERI66a TACGACCATGGCAC
AACGGGAAACGGTC
NcoI sense primer creB response
regulator C-terminal XFP fusions
this work
ERI66b TATATGGATCCCAGGC
CCCTCAGGCTATATC
BamH I reverse primer creB response
regulator C-terminal XFP fusions
this work
ERI67a TACGACCATGGCAA
AACTGTTGATTGTC
NcoI sense primer cusR response
regulator C-terminal XFP fusions
this work
ERI67b TATATGGATCCCTG
ACCATCCGGCACC
BamH I reverse primer cusR response
regulator C-terminal XFP fusions
this work
ERI68a TACGACCATGGCAC
GAATTTTACTGATAG
NcoI sense primer qseB response
regulator C-terminal XFP fusions
this work
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ERI68b TATATGGATCCTTTC
TCACCTAATGTG
BamH I reverse primer qseB response
regulator C-terminal XFP fusions
this work
ERI69a TACGACCATGGCAA
AGATTCTACTTATTG
NcoI sense primer yedW response
regulator C-terminal XFP fusions
this work
ERI69b TATATGGATCCTTTT
TTTACCGCTACG
BamH I reverse primer yedW response
regulator C-terminal XFP fusions
this work
ERI70a TACGACCATGGCAAC
AGCTCCATTAACCC
NcoI sense primer citB response
regulator C-terminal XFP fusions
this work
ERI70b TATATGGATCCCCCA
CTGTGGTATATGCG
BamH I reverse primer citB response
regulator C-terminal XFP fusions
this work
ERI71a TACGACCATGGCAATC
AATGTATTAATTATCG
NcoI sense primer dcuR response
regulator C-terminal XFP fusions
this work
ERI71b TATATAGATCTTTGG
CAATATTGTTTCAG
BglII reverse primer dcuR response
regulator C-terminal XFP fusions
this work
ERI74 GTCGTAAAGTCAT
TCAGGGTG
- sequencing primer binding to evgS
II (sense)
this work
ERI75a TACGACCATGGCAAT
TAAAGTCTTAATTGTC
NcoI sense primer lytR response
regulator C-terminal XFP fusions
this work
ERI75b TATATAGATCTCAGGCC
AATCGCCTCTTTTAAGC
BglII reverse primer lytR response
regulator C-terminal XFP fusions
this work
ERI76a TACGACCATGGCAAAA
GTCATCATTGTTGAAG
NcoI sense primer ypdB response
regulator C-terminal XFP fusions
this work
ERI76b TATATAGATCTAAGA
TGCATTAACTGGCG
BglII reverse primer ypdB response
regulator C-terminal XFP fusions
this work
ERI77a TACGACCATGGCAAAA
CCAACGTCGGTGATC
NcoI sense primer fimZ response
regulator C-terminal XFP fusions
this work
ERI77b TATATAGATCTTATTA
ATTCGTATAATTTGG
BglII reverse primer fimZ response
regulator C-terminal XFP fusions
this work
ERI78a TACGACCATGGCAAG
TAATCAGGAACCGGC
NcoI sense primer narL response
regulator C-terminal XFP fusions
this work
ERI79a TACGATCATGATAAT
CAACGTTCTACTTG
BspH I sense primer uvrY response
regulator C-terminal XFP fusions
this work
ERI81a TACGACCATGGCAAAC
GCAATAATTATTGATG
NcoI sense primer evgA response
regulator C-terminal XFP fusions
this work
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ERI81b TATATAGATCTGCCGA
TTTTGTTACGTTG
BglII reverse primer evgA response
regulator C-terminal XFP fusions
this work
ERI82a TACGACCATGGCACCT
GAAGCAACACCTTTTC
NcoI sense primer narP response
regulator C-terminal XFP fusions
this work
ERI82b TATATAGATCTTTGTG
CCCCGCGTTGTTG
BglII reverse primer narP response
regulator C-terminal XFP fusions
this work
ERI83a TACGACCATGGCAATC
ACCGTTGCCCTTATAG
NcoI sense primer uhpA response
regulator C-terminal XFP fusions
this work
ERI83b TATATAGATCTCCAGC
CATCAAACATGCG
BglII reverse primer uhpA response
regulator C-terminal XFP fusions
this work
ERI84a TACGACCATGGCAACT
GCTATTAATCGCATC
NcoI sense primer atoC response
regulator C-terminal XFP fusions
this work
ERI85a TACGACCATGGCAAC
GCACGATAATATCG
NcoI sense primer hydG response
regulator C-terminal XFP fusions
this work
ERI85b TATATAGATCTACGCGA
CAGTTTTGCCAATAG
BglII reverse primer hydG response
regulator C-terminal XFP fusions
this work
ERI86a TACGACCATGGCACAA
CGAGGGATAGTCTG
NcoI sense primer ntrC response
regulator C-terminal XFP fusions
this work
ERI86b TATATAGATCTCTCCAT
CCCCAGCTCTTTTAAC
BglII reverse primer ntrC response
regulator C-terminal XFP fusions
this work
ERI87a TACGACCATGGCAAG
CCATAAACCTGCGC
NcoI sense primer yfhA response
regulator C-terminal XFP fusions
this work
ERI87b TATATAGATCTTTCCTT
GAAATCGTTTGC
BglII reverse primer yfhA response
regulator C-terminal XFP fusions
this work
ERI88a TACGACCATGGCAACG
CAGCCATTGGTCGG
NcoI sense primer rssB response
regulator C-terminal XFP fusions
this work
ERI90a TACGACCATGGCAAAC
AATATGAACG
NcoI sense primer rcsB response
regulator C-terminal XFP fusions
this work
ERI90b TATATAGATCTGTCTT
TATCTGCCGGAC
BglII reverse primer rcsB response
regulator C-terminal XFP fusions
this work
ERI95a ATATACCATGGGTAAA
TACCTTGCTTCTTTTCG
NcoI sense primer rcsC His-kinase
C-terminal YFP fusions (extended
N-term)
this work
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ERI95b TACGAAAGCTTCGATATT
TATTGATGCGTTCATGCA
HindIII reverse primer rcsC His-kinase
(extended N-term)
this work
ERI97 GGCGTGCGTTATCAG - sequencing primer kdpD II (sense) this work
ERI101 TACGACCATGGCATGA
AGCACATAATGG
NcoI sense primer baeR response
regulator with additional 100bp
upstream
this work
ERI105 TATATGGATCCCTGAC
TTGATAATGTCTC
BamH I reverse primer uvrY response
regulator C-terminal XFP fusions
this work
ERI109 ATCGTCTCGAGGTTG
GAGTCATTACCC
XhoI new sense primer flhD promotor
region
this work
ERI110 AGCTAGGATCTGAAA
ATGCGCTCCTGATG
BamH I reverse primer narL response
regulator C-terminal XFP fusions
this work
ERI111 AGCTAGGATCTTTCTG
CAGACAACATCAAG
BamH I reverse primer rssB response
regulator C-terminal XFP fusions
this work
ERI112a ATCTGCCATGGGTATGA
TTAAAGTCTTAATTG
NcoI sense primer yehT response
regulator C-terminal XFP fusions
this work
ERI112b AGCTAGGATCCCAGGC
CAATCGCCTCTTTTAAG
BamH I reverse primer yehT response
regulator C-terminal XFP fusions
this work
ERI113a ATCTGTCATGAGTATGT
ACGATTTTAATCTGG
BspH I sense primer yehU histidine kinase
C-terminal XFP fusions
this work
ERI113b AGCTAGGATCCTGCCT
CGTCCCTCCATGG
BamH I reverse primer yehU histidine
kinase C-terminal XFP fusions
this work
ERI119 TACGAGGATCCTACAT
CCGCCGGATCGATAC
BamH I new reverse primer atoC response
regulator C-terminal XFP fusions
this work
ERI120 ATATATCATGATGTAC
GATTTTAATCTGG
BspH I sense primer lytS His-kinase
C-terminal XFP fusions
this work
ERI121 CAGTCATAGCCGAATAGCCT - verification primer k1 kanamycin
cassette knockouts (Datsenko and
Wanner)
this work
ERI122 CGGTGCCCTGAATGA
ACTGC
- verification primer k2 kanamycin
cassette knockouts (Datsenko and
Wanner)
this work
ERI123a ATCTGAAGCTTGGTAA
GTTCAAACTTAACC
HindIII 300 bp upstream envZ deletion,
sense primer
this work
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ERI124a ATCTGCATATGATAAAC
GGGAGGCGAAGGTG
NdeI 300 bp downstream envZ deletion,
sense primer
this work
ERI124b TAGCTGTTAACCGCCA
TCCTCAACGGTTCG
HpaI 300 bp downstream envZ deletion,
reverse primer
this work
ERI125a ATCTGAAGCTTCTGTA
CTACAGCGTCTAAGTG
HindIII 300 bp upstream ntrB deletion,
sense primer
this work
ERI126a TAGCTCATATGAGGTG
ACGTTTATGCAACGAG
NdeI 300 bp downstream ntrB deletion,
sense primer
this work
ERI126b TAGCTGTTAACCTTGTT
GATAGGCGCTGACG
HpaI 300 bp downstream ntrB deletion,
reverse primer
this work
ERI127a ATCTGAAGCTTCTCTGA
TGCGCCGAACCAAC
HindIII 300 bp upstream qseC deletion,
sense primer
this work
ERI128a ATCTGCATATGCTTCTC
TGTCTATGAGAGCCG
NdeI 300 bp downstream qseC deletion,
sense primer
this work
ERI128b TAGCTGTTAACGCTTT
CAATAAGTATGACTGG
HpaI 300 bp downstream qseC deletion,
sense primer
this work
ERI129a ATCTGAAGCTTCTACGA
TATAACCAATAGTAAG
HindIII 300 bp upstream rcsC deletion,
sense primer
this work
ERI130a ATCTGCATATGGACGGA
TAAGGCGTTTACGC
NdeI 300 bp downstream rcsC deletion,
sense primer
this work
ERI130b TAGCTGTTAACGCCAGA
AGAAATCTGCGATG
HpaI 300 bp downstream rcsC deletion,
reverse primer
this work
ERI131 TAGCTGCGGCCGCTCAT
GCTTTAGAGCCGTCC
NotI 300 bp upstream envZ deletion,
reverse primer
this work
ERI132 TAGCTGCGGCCGCAAAG
CAGTCTCCTGAACAGG
NotI 300 bp upstream ntrB deletion,
reverse primer
this work
ERI133 TAGCTGCGGCCGCTCATT
TCTCACCTAATGTGTAAC
NotI 300 bp upstream qseC deletion,
reverse primer
this work
ERI134 TAGCTGCGGCCGCGTAG
CGCGAGGCTTTCAGGG
NotI 300 bp upstream rcsC deletion,
reverse primer
this work
ERI135 CCTTCTTGACGAGTTC - sequencing primer binding to end
of kan-cassette (sense)
this work
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ERI140a TACGAGCTAGCCTTAC
CCATCTGGGGGC
NheI 500 bp upstream evgS
chromosomal C-terminal YFP
fusion, sense primer
this work
ERI140b TAGCTGGTACCGTCA
TTTTTCTGACAG
KpnI 500 bp upstream evgS
chromosomal C-terminal YFP
fusion, reverse primer
this work
ERI140c TACGAGAATTCATAGC
GGCTCCCACAATG
HindIII 500 bp downstream evgS
chromosomal C-terminal YFP
fusion, sense primer
this work
ERI140d TAGCTGTTAACCTACA
TGGCACCTTTTG
HpaI 500 bp downstream evgS
chromosomal C-terminal YFP
fusion, reverse primer
this work
ERI141a TACGAAAGCTTGGCA
CAGCAATATCCGTC
HindIII 500 bp upstream torS
chromosomal C-terminal YFP
fusion, sense primer
this work
ERI141b TAGCTGGTACCAATCG
CGTTCAGGTCTTTC
KpnI 500 bp upstream torS
chromosomal C-terminal YFP
fusion, reverse primer
this work
ERI141c TACGAGAATTCATCAA
TATCAGCCAGTTAAG
EcoRI 500 bp downstream torS
chromosomal C-terminal YFP
fusion, sense primer
this work
ERI141d TAGCTCTTAAGGCCGA
CCAAACAGTTTG
AflII 500 bp downstream torS
chromosomal C-terminal YFP
fusion, reverse primer
this work
ERI142a TACGAAAGCTTCTGCT
GGAAGTGGCGG
HindIII 500 bp upstream baeS
chromosomal C-terminal YFP
fusion, sense primer
this work
ERI142b TAGCTGGTACCTACTT
CTCTCTGTAAATC
KpnI 500 bp upstream baeS
chromosomal C-terminal YFP
fusion, reverse primer
this work
ERI142c TACGACATATGGGGA
TTTACAGAGAGAAG
NdeI 500 bp downstream baeS
chromosomal C-terminal YFP
fusion, sense primer
this work
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ERI142d TAGCTCTTAAGCAGCA
GACGAAATTCCGC
AflII 500 bp downstream baeS
chromosomal C-terminal YFP
fusion, reverse primer
this work
ERI143a TACGAAGCTTCGCGG
TTAACAGAGAAC
HindIII 500 bp upstream yedV
chromosomal C-terminal YFP
fusion, sense primer
this work
ERI143b TAGCTGGTACCATTTC
TTTGCGGTAACG
KpnI 500 bp upstream yedV
chromosomal C-terminal YFP
fusion, reverse primer
this work
ERI143c TACGACATATGCATAG
GGCTTCAGTACGC
NdeI 500 bp downstream yedV
chromosomal C-terminal YFP
fusion, sense primer
this work
ERI143d TAGCTACGCGTGTGGTC
ATGGCGCACTTATTGG
AflIII 500 bp downstream yedV
chromosomal C-terminal YFP
fusion, reverse primer
this work
ERI144a TACGAAAGCTTGGTCA
GCGATATGCTGTTTC
HindIII 500 bp upstream cusS
chromosomal C-terminal YFP
fusion, sense primer
this work
ERI144b TAGCTGGTACCAGCG
GGTAATGTGATAAC
KpnI 500 bp upstream cusS
chromosomal C-terminal YFP
fusion, reverse primer
this work
ERI144c TACGAGAATTCTCCTT
CAGCAAACGGCAAC
EcoRI 500 bp downstream cusS
chromosomal C-terminal YFP
fusion, sense primer
this work
ERI144d TAGCTCTTAAGAACAT
CACGCTGAGTATCG
AflII 500 bp downstream cusS
chromosomal C-terminal YFP
fusion, reverse primer
this work
ERI145a TACGAAGCTTGCCTG
CGCGAGGCGTTTG
HindIII 500 bp upstream citA
chromosomal C-terminal YFP
fusion, sense primer
this work
ERI145b TAGCTGATATCACGA
TCAATAGGGTTAATG
EcoRV 500 bp upstream citA
chromosomal C-terminal YFP
fusion, reverse primer
this work
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ERI145c TACGAGAATTCGCTC
CATTAACCCTATTG
EcoRI 500 bp downstream citA
chromosomal C-terminal YFP
fusion, sense primer
this work
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Table 6.5: Bacterial strains used in this study.
Strain Relevant genotype Source or Reference
E. coli K-12
BW25113 (lacIq rrnBT14 ΔlacZWJ16 hsdR514 ΔaraBADAH33 ΔrhaBADLD78) [197]
DH5α F Φ80lacZΔ(lacZYA-argF)U169 deoR recA1 endA1 Invitrogen, Karlsruhe
hsdR17(r-km
-
k)phoA supE44 thi-1 gyrA96 relA1 λ
-) [240]
ES1 ΔuhpB (removed kanr from JW3643) this work
ES2 ΔphoQ (removed kanr from JW1115) this work
ES3 ΔyedV (removed kanr from JW1951) this work
ES4 ΔbarA (removed kanr from JW2757) this work
ES5 ΔdcuS (removed kanr from JW4086) this work
JW0390 ∆phoR::kanR Keio collection
JW0611 ∆citA::kanR Keio collection
JW1115 ∆phoQ::kanR Keio collection
JW1213 ∆narX::kanR Keio collection
JW1951 ∆yedV::kanR Keio collection
JW2063 ∆baeS::kanR Keio collection
JW2213 ∆atoS::kanR Keio collection
JW2453 ∆narQ::kanR Keio collection
JW2994 ∆qseC::kanR Keio collection
JW3367 ∆envZ::kanR Keio collection
JW3643 ∆uhpB::kanR Keio collection
JW3882 ∆cpxA::kanR Keio collection
JW3967 ∆hydH(zraS)::kanR Keio collection
JW4073 ∆basS::kanR Keio collection
JW4086 ∆dcuS::kanR Keio collection
JW4362 ∆creC::kanR Keio collection
JW5082 ∆cusS::kanR Keio collection
JW5388 ∆ypdA::kanR Keio collection
JW5407 ∆yfhK::kanR Keio collection
JW5917 ∆rcsC::kanR Keio collection
LL5 ∆(cheR-cheZ), ∆flgM L. Løvdok, personal gift
MG1655 wild type strain [11]
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Table 6.6: Chemicals and consumables.
1 kB plus ladder (1 µg/µL) Invitrogen, Karlsruhe
α-Ketoglutaric acid Applichem, Darmstadt
Acetoacetate Applichem, Darmstadt
Agar bacteriology Applichem, Darmstadt
Agarose electrophoresis grade Invitrogen, Karlsruhe
Amoniumsulfate Merck, Darmstadt
Ampicillin Applichem, Darmstadt
Bacto tryptone Difco, Hamburg
Bacto yeast extract Difco, Hamburg
Bromphenol blue Applichem, Darmstadt
Casein hydrolysate Oxoid, Wesel
Chloramphenicol Applichem, Darmstadt
Copper sulfate Applichem, Darmstadt
D-glucose Applichem, Darmstadt
di-Potassium hydrophosphate Grüssing, Filsum
DL-lactic acid Sigma-Aldrich, Deisenhofen
dNTPs Invitrogen, Karlsruhe
EDTA Merck, Darmstadt
Ethanol Applichem, Darmstadt
Ethidiumbromide Applichem, Darmstadt
Ferric sulfate Applichem, Darmstadt
Fumaric acid Sigma-Aldrich, Deisenhofen
Glucose-6-phosphate Applichem, Darmstadt
Glycerol Roth, Karlsruhe
Indole Sigma-Aldrich, Deisenhofen
IPTG Roth, Karlsruhe
Kanamycin sulphate Applichem, Darmstadt
L-arabinose Sigma-Aldrich, Deisenhofen
L-methionine Sigma-Aldrich, Deisenhofen
L-serine Sigma-Aldrich, Deisenhofen
Magnesium chloride Invitrogen, Karlsruhe
Magnesium sulfate Merck, Darmstadt
Pageruler Prestained Protein Ladder Fermentas, St. Leon-Rot
Polythyleneglycol Sigma-Aldrich, Deisenhofen
Potassium chloride Applichem, Darmstadt
Potassium hydrophosphate Grüssing, Filsum
Potassium phosphate Riedel de Haёn, Seelze
Sodium Citrate Applichem, Darmstadt
Sodium chloride Applichem, Darmstadt
Sodium hydroxide Applichem, Darmstadt
Sodium nitrate Applichem, Darmstadt
Sodium nitrite Applichem, Darmstadt
Sucrose Roth, Karlsruhe
TEMED Applichem, Darmstadt
TMANO Sigma-Aldrich, Deisenhofen
Tris Roth, Karlsruhe
Xylencyanol Applichem, Darmstadt
Zinc chloride Sigma-Aldrich, Deisenhofen
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